{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:05:13Z","timestamp":1794924313580,"version":"4.9.1"},"reference-count":466,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02558-6","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:00:38Z","timestamp":1771840838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The application of experimental models for the drug discovery for digestive tumors"],"prefix":"10.1186","volume":"25","author":[{"given":"Linxiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"3","key":"2558_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin"},{"issue":"3","key":"2558_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrgastro.2012.19","volume":"9","author":"M Rugge","year":"2012","unstructured":"Rugge M, Fassan M, Graham DY. Clinical guidelines: secondary prevention of gastric cancer. Nat Reviews Gastroenterol Hepatol. 2012;9(3):128\u20139. https:\/\/doi.org\/10.1038\/nrgastro.2012.19.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2558_CR3","doi-asserted-by":"publisher","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 2018, 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","DOI":"10.3322\/caac.21492"},{"issue":"1","key":"2558_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"Cancer J Clin"},{"issue":"7","key":"2558_CR5","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sinica B. 2022;12(7):3049\u201362. https:\/\/doi.org\/10.1016\/j.apsb.2022.02.002.","journal-title":"Acta Pharm Sinica B"},{"key":"2558_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ebiom.2016.02.023","volume":"5","author":"CM Sakolish","year":"2016","unstructured":"Sakolish CM, Esch MB, Hickman JJ, Shuler ML, Mahler GJ. Modeling barrier tissues in vitro: Methods, Achievements, and challenges. EBioMedicine. 2016;5:30\u20139. https:\/\/doi.org\/10.1016\/j.ebiom.2016.02.023.","journal-title":"EBioMedicine"},{"issue":"3","key":"2558_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/clpt.2009.293","volume":"87","author":"KI Kaitin","year":"2010","unstructured":"Kaitin KI. Deconstructing the drug development process: the new face of innovation. Clin Pharmacol Ther. 2010;87(3):356\u201361. https:\/\/doi.org\/10.1038\/clpt.2009.293.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2558_CR8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5114\/aoms.2016.63743","volume":"14","author":"M Kapa\u0142czy\u0144ska","year":"2018","unstructured":"Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V, Ibbs M, Bli\u017aniak R, \u0141uczewski \u0141, Lamperska K. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Archives Med Science: AMS. 2018;14(4):910\u20139. https:\/\/doi.org\/10.5114\/aoms.2016.63743.","journal-title":"Archives Med Science: AMS"},{"key":"2558_CR9","first-page":"1173","volume":"31","author":"YV Dobrynin","year":"1963","unstructured":"Dobrynin YV, Establishment and characteristics of cell strains from some epithelial tumors of human origin. J Natl Cancer Inst. 1963;31:1173\u201395.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2558_CR10","first-page":"969","volume":"38","author":"EH Leiter","year":"1978","unstructured":"Leiter EH, Malinoski FJ, Eppig JJ. An epithelial cell line with chronic polyoma infection established from a spontaneous mouse pancreatic adenocarcinoma. Cancer Res. 1978;38(4):969\u201377.","journal-title":"Cancer Res"},{"issue":"4","key":"2558_CR11","first-page":"1703","volume":"43","author":"SC Barranco","year":"1983","unstructured":"Barranco SC, Townsend CM Jr., Casartelli C, Macik BG, Burger NL, Boerwinkle WR, Gourley WK. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 1983;43(4):1703\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"2558_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0165-4608(82)90076-0","volume":"6","author":"TR Chen","year":"1982","unstructured":"Chen TR, Hay RJ, Macy ML. Karyotype consistency in human colorectal carcinoma cell lines established in vitro. Cancer Genet Cytogenet. 1982;6(2):93\u2013117. https:\/\/doi.org\/10.1016\/0165-4608(82)90076-0.","journal-title":"Cancer Genet Cytogenet"},{"key":"2558_CR13","doi-asserted-by":"publisher","unstructured":"Chabner BA. NCI-60 cell line screening: A radical departure in its time. J Natl Cancer Inst. 2016;108(5). https:\/\/doi.org\/10.1093\/jnci\/djv388.","DOI":"10.1093\/jnci\/djv388"},{"issue":"8","key":"2558_CR14","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/bit.28496","volume":"120","author":"CP Prasad","year":"2023","unstructured":"Prasad CP, Tripathi SC, Kumar M, Mohapatra P. Passage number of cancer cell lines: Importance, intricacies, and way-forward. Biotechnol Bioeng. 2023;120(8):2049\u201355. https:\/\/doi.org\/10.1002\/bit.28496.","journal-title":"Biotechnol Bioeng"},{"issue":"7","key":"2558_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrd3480","volume":"10","author":"DC Swinney","year":"2011","unstructured":"Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discovery. 2011;10(7):507\u201319. https:\/\/doi.org\/10.1038\/nrd3480.","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"2558_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrd3368","volume":"10","author":"R Macarron","year":"2011","unstructured":"Macarron R, Banks MN, Bojanic D, Burns DJ, Cirovic DA, Garyantes T, Green DV, Hertzberg RP, Janzen WP, Paslay JW, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discovery. 2011;10(3):188\u201395. https:\/\/doi.org\/10.1038\/nrd3368.","journal-title":"Nat Rev Drug Discovery"},{"issue":"7899","key":"2558_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","volume":"603","author":"P Jaaks","year":"2022","unstructured":"Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, Dwane L, Sassi F, Lightfoot H, Barthorpe S, et al. Effective drug combinations in breast, colon and pancreatic cancer cells. Nature. 2022;603(7899):166\u201373. https:\/\/doi.org\/10.1038\/s41586-022-04437-2.","journal-title":"Nature"},{"issue":"6096","key":"2558_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Sci (New York NY). 2012;337(6096):816\u201321. https:\/\/doi.org\/10.1126\/science.1225829.","journal-title":"Sci (New York NY)"},{"issue":"39","key":"2558_CR19","doi-asserted-by":"publisher","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","volume":"109","author":"G Gasiunas","year":"2012","unstructured":"Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA. 2012;109(39):E2579\u20132586. https:\/\/doi.org\/10.1073\/pnas.1208507109.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2558_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet. 2010;11(9):636\u201346. https:\/\/doi.org\/10.1038\/nrg2842.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2558_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3486","volume":"14","author":"JK Joung","year":"2013","unstructured":"Joung JK, Sander JD. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol. 2013;14(1):49\u201355. https:\/\/doi.org\/10.1038\/nrm3486.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2558_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nmeth.2598","volume":"10","author":"ML Maeder","year":"2013","unstructured":"Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK. CRISPR RNA-guided activation of endogenous human genes. Nat Methods. 2013;10(10):977\u20139. https:\/\/doi.org\/10.1038\/nmeth.2598.","journal-title":"Nat Methods"},{"issue":"7536","key":"2558_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517(7536):583\u20138. https:\/\/doi.org\/10.1038\/nature14136.","journal-title":"Nature"},{"issue":"1","key":"2558_CR24","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/s41467-018-05067-x","volume":"9","author":"J Weltner","year":"2018","unstructured":"Weltner J, Balboa D, Katayama S, Bespalov M, Krjut\u0161kov K, Jouhilahti EM, Trokovic R, Kere J, Otonkoski T. Human pluripotent reprogramming with CRISPR activators. Nat Commun. 2018;9(1):2643. https:\/\/doi.org\/10.1038\/s41467-018-05067-x.","journal-title":"Nat Commun"},{"issue":"7391","key":"2558_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Leh\u00e1r J, Kryukov GV, Sonkin D, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603\u20137. https:\/\/doi.org\/10.1038\/nature11003.","journal-title":"Nature"},{"issue":"Supplement 1","key":"2558_CR26","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2024-211758","volume":"144","author":"J Schmoellerl","year":"2024","unstructured":"Schmoellerl J, Maerschalk R, Weissenboeck M, Ali J, K\u00f6cher T, Bundalo A, Andersch F, Vogt V, Sajtos B, Bayerl J, et al. Systematic identification of Gene-Drug interactions using an advanced CRISPR screening platform to predict therapy response across cancer types. Blood. 2024;144(Supplement 1):2235\u20132235. https:\/\/doi.org\/10.1182\/blood-2024-211758.","journal-title":"Blood"},{"issue":"1","key":"2558_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41568-024-00758-8","volume":"25","author":"J Zuber","year":"2025","unstructured":"Zuber J, Palm W. Modelling and Deciphering tumour metabolism in CRISPR screens. Nat Rev Cancer. 2025;25(1):1\u20132. https:\/\/doi.org\/10.1038\/s41568-024-00758-8.","journal-title":"Nat Rev Cancer"},{"key":"2558_CR28","doi-asserted-by":"publisher","unstructured":"Queralt C, Moreta-Moraleda C, Costa M, Grau-Leal F, Diesch J, Vendrell-Ayats C, Musul\u00e9n E, Bug\u00e9s C, Manzano JL, Cabrero S et al. Loss-of-Function genetic Screen Unveils Synergistic Efficacy of PARG Inhibition with Combined 5-Fluorouracil and Irinotecan Treatment in Colorectal Cancer. bioRxiv 2025:2025.2003.2029.644889. https:\/\/doi.org\/10.1101\/2025.03.29.644889.","DOI":"10.1101\/2025.03.29.644889"},{"issue":"10","key":"2558_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez F, Mui\u00f1os F, Sent\u00eds I, Deu-Pons J, Reyes-Salazar I, Arnedo-Pac C, Mularoni L, Pich O, Bonet J, Kranas H, et al. A compendium of mutational cancer driver genes. Nat Rev Cancer. 2020;20(10):555\u201372. https:\/\/doi.org\/10.1038\/s41568-020-0290-x.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2558_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1349-7006.2005.00011.x","volume":"96","author":"T Nakamura","year":"2005","unstructured":"Nakamura T. Retroviral insertional mutagenesis identifies oncogene Cooperation. Cancer Sci. 2005;96(1):7\u201312. https:\/\/doi.org\/10.1111\/j.1349-7006.2005.00011.x.","journal-title":"Cancer Sci"},{"issue":"6166","key":"2558_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. Sci (New York NY). 2014;343(6166):80\u20134. https:\/\/doi.org\/10.1126\/science.1246981.","journal-title":"Sci (New York NY)"},{"issue":"5927","key":"2558_CR32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/304596a0","volume":"304","author":"H Land","year":"1983","unstructured":"Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 1983;304(5927):596\u2013602. https:\/\/doi.org\/10.1038\/304596a0.","journal-title":"Nature"},{"issue":"6743","key":"2558_CR33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/22780","volume":"400","author":"WC Hahn","year":"1999","unstructured":"Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature. 1999;400(6743):464\u20138. https:\/\/doi.org\/10.1038\/22780.","journal-title":"Nature"},{"key":"2558_CR34","doi-asserted-by":"publisher","first-page":"156161","DOI":"10.1016\/j.phymed.2024.156161","volume":"135","author":"YY Lu","year":"2024","unstructured":"Lu YY, Fang YY, Wang SS, Guo J, Song JL, Zhu L, Lin ZK, Wang R, Zhang SY, Qiu WS, et al. Cepharanthine sensitizes gastric cancer cells to chemotherapy by targeting TRIB3-FOXO3-FOXM1 axis to inhibit autophagy. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2024;135:156161. https:\/\/doi.org\/10.1016\/j.phymed.2024.156161.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"issue":"1","key":"2558_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/s0006-3495(00)76279-5","volume":"79","author":"CM Lo","year":"2000","unstructured":"Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of the substrate. Biophys J. 2000;79(1):144\u201352. https:\/\/doi.org\/10.1016\/s0006-3495(00)76279-5.","journal-title":"Biophys J"},{"issue":"25","key":"2558_CR36","doi-asserted-by":"publisher","first-page":"13661","DOI":"10.1073\/pnas.94.25.13661","volume":"94","author":"RJ Pelham Jr","year":"1997","unstructured":"Pelham RJ Jr., Wang Y. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA. 1997;94(25):13661\u20135. https:\/\/doi.org\/10.1073\/pnas.94.25.13661.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2558_CR37","doi-asserted-by":"publisher","first-page":"e03282","DOI":"10.7554\/eLife.03282","volume":"3","author":"MR Ng","year":"2014","unstructured":"Ng MR, Besser A, Brugge JS, Danuser G. Mapping the dynamics of force transduction at cell-cell junctions of epithelial clusters. eLife. 2014;3:e03282. https:\/\/doi.org\/10.7554\/eLife.03282.","journal-title":"eLife"},{"issue":"2","key":"2558_CR38","doi-asserted-by":"publisher","first-page":"188350","DOI":"10.1016\/j.bbcan.2020.188350","volume":"1873","author":"R Nguyen","year":"2020","unstructured":"Nguyen R, Bae SDW, Zhou G, Read SA, Ahlenstiel G, George J, Qiao L. Application of organoids in translational research of human diseases with a particular focus on Gastrointestinal cancers. Biochim Et Biophys Acta Reviews Cancer. 2020;1873(2):188350. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188350.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"issue":"1","key":"2558_CR39","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.18632\/oncotarget.13857","volume":"8","author":"S D\u00e4ster","year":"2017","unstructured":"D\u00e4ster S, Amatruda N, Calabrese D, Ivanek R, Turrini E, Droeser RA, Zajac P, Fimognari C, Spagnoli GC, Iezzi G, et al. Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment. Oncotarget. 2017;8(1):1725\u201336. https:\/\/doi.org\/10.18632\/oncotarget.13857.","journal-title":"Oncotarget"},{"issue":"1","key":"2558_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1242\/jcs.188102","volume":"130","author":"A Riedl","year":"2017","unstructured":"Riedl A, Schlederer M, Pudelko K, Stadler M, Walter S, Unterleuthner D, Unger C, Kramer N, Hengstschl\u00e4ger M, Kenner L, et al. Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses. J Cell Sci. 2017;130(1):203\u201318. https:\/\/doi.org\/10.1242\/jcs.188102.","journal-title":"J Cell Sci"},{"key":"2558_CR41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fbioe.2019.00144","volume":"7","author":"J Costa","year":"2019","unstructured":"Costa J, Ahluwalia A. Advances and current challenges in intestinal in vitro model engineering: A digest. Front Bioeng Biotechnol. 2019;7:144. https:\/\/doi.org\/10.3389\/fbioe.2019.00144.","journal-title":"Front Bioeng Biotechnol"},{"key":"2558_CR42","doi-asserted-by":"publisher","unstructured":"Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, Bj\u00f8rnslett M, Meza-Zepeda LA, Ekn\u00e6s M, Lind GE, et al. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Mol Cancer. 2017;16(1):116. https:\/\/doi.org\/10.1186\/s12943-017-0691-y.","DOI":"10.1186\/s12943-017-0691-y"},{"issue":"1","key":"2558_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","volume":"21","author":"Y Sambuy","year":"2005","unstructured":"Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005;21(1):1\u201326. https:\/\/doi.org\/10.1007\/s10565-005-0085-6.","journal-title":"Cell Biol Toxicol"},{"key":"2558_CR44","doi-asserted-by":"publisher","first-page":"122004","DOI":"10.1016\/j.ijpharm.2022.122004","volume":"624","author":"N Panse","year":"2022","unstructured":"Panse N, Gerk PM. The Caco-2 model: modifications and enhancements to improve efficiency and predictive performance. Int J Pharm. 2022;624:122004. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122004.","journal-title":"Int J Pharm"},{"issue":"4","key":"2558_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.4.4.395","volume":"4","author":"H Sun","year":"2008","unstructured":"Sun H, Chow EC, Liu S, Du Y, Pang KS. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol. 2008;4(4):395\u2013411. https:\/\/doi.org\/10.1517\/17425255.4.4.395.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2558_CR46","doi-asserted-by":"publisher","first-page":"15377","DOI":"10.1038\/srep15377","volume":"5","author":"A Frattini","year":"2015","unstructured":"Frattini A, Fabbri M, Valli R, De Paoli E, Montalbano G, Gribaldo L, Pasquali F, Maserati E. High variability of genomic instability and gene expression profiling in different HeLa clones. Sci Rep. 2015;5:15377. https:\/\/doi.org\/10.1038\/srep15377.","journal-title":"Sci Rep"},{"issue":"7718","key":"2558_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560(7718):325\u201330. https:\/\/doi.org\/10.1038\/s41586-018-0409-3.","journal-title":"Nature"},{"key":"2558_CR48","doi-asserted-by":"publisher","unstructured":"Hynds RE, Vladimirou E, Janes SM. The secret lives of cancer cell lines. Dis Models Mech. 2018;11(11). https:\/\/doi.org\/10.1242\/dmm.037366.","DOI":"10.1242\/dmm.037366"},{"issue":"6","key":"2558_CR49","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","volume":"29","author":"P Goossens","year":"2019","unstructured":"Goossens P, Rodriguez-Vita J, Etzerodt A, Masse M, Rastoin O, Gouirand V, Ulas T, Papantonopoulou O, Van Eck M, Auphan-Anezin N, et al. Membrane cholesterol efflux drives tumor-Associated macrophage reprogramming and tumor progression. Cell Metabol. 2019;29(6):1376\u2013e13891374. https:\/\/doi.org\/10.1016\/j.cmet.2019.02.016.","journal-title":"Cell Metabol"},{"issue":"1","key":"2558_CR50","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","volume":"13","author":"P Yang","year":"2022","unstructured":"Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, Su C, Luo X, Lu Q, Liao M, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13(1):5782. https:\/\/doi.org\/10.1038\/s41467-022-33349-y.","journal-title":"Nat Commun"},{"issue":"41","key":"2558_CR51","doi-asserted-by":"publisher","first-page":"15153","DOI":"10.1021\/acs.analchem.2c05734","volume":"95","author":"P Chen","year":"2023","unstructured":"Chen P, Han Y, Wang L, Zheng Y, Zhu Z, Zhao Y, Zhang M, Chen X, Wang X, Sun C. Spatially resolved metabolomics combined with the 3D Tumor-Immune cell coculture spheroid highlights metabolic alterations during antitumor immune response. Anal Chem. 2023;95(41):15153\u201361. https:\/\/doi.org\/10.1021\/acs.analchem.2c05734.","journal-title":"Anal Chem"},{"key":"2558_CR52","doi-asserted-by":"publisher","unstructured":"Jeong SR, Kang M. Exploring tumor-Immune interactions in Co-Culture models of T cells and tumor organoids derived from patients. Int J Mol Sci. 2023;24(19). https:\/\/doi.org\/10.3390\/ijms241914609.","DOI":"10.3390\/ijms241914609"},{"issue":"6","key":"2558_CR53","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 2020;78(6):1019\u201333. https:\/\/doi.org\/10.1016\/j.molcel.2020.05.034.","journal-title":"Mol Cell"},{"key":"2558_CR54","doi-asserted-by":"publisher","first-page":"39999","DOI":"10.1038\/srep39999","volume":"7","author":"A Halama","year":"2017","unstructured":"Halama A, Guerrouahen BS, Pasquier J, Satheesh NJ, Suhre K, Rafii A. Nesting of colon and ovarian cancer cells in the endothelial niche is associated with alterations in glycan and lipid metabolism. Sci Rep. 2017;7:39999. https:\/\/doi.org\/10.1038\/srep39999.","journal-title":"Sci Rep"},{"key":"2558_CR55","doi-asserted-by":"publisher","first-page":"1053920","DOI":"10.3389\/fimmu.2023.1053920","volume":"14","author":"E Strating","year":"2023","unstructured":"Strating E, Verhagen MP, Wensink E, D\u00fcnnebach E, Wijler L, Aranguren I, De la Cruz AS, Peters NA, Hageman JH, van der Net MMC, et al. Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer. Front Immunol. 2023;14:1053920. https:\/\/doi.org\/10.3389\/fimmu.2023.1053920.","journal-title":"Front Immunol"},{"issue":"10","key":"2558_CR56","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","volume":"8","author":"F Pampaloni","year":"2007","unstructured":"Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8(10):839\u201345. https:\/\/doi.org\/10.1038\/nrm2236.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6951","key":"2558_CR57","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/424870a","volume":"424","author":"A Abbott","year":"2003","unstructured":"Abbott A. Cell culture: biology\u2019s new dimension. Nature. 2003;424(6951):870\u20132. https:\/\/doi.org\/10.1038\/424870a.","journal-title":"Nature"},{"issue":"8","key":"2558_CR58","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","volume":"34","author":"EC Costa","year":"2016","unstructured":"Costa EC, Moreira AF, de Melo-Diogo D, Gaspar VM, Carvalho MP, Correia IJ. 3D tumor spheroids: an overview on the tools and techniques used for their analysis. Biotechnol Adv. 2016;34(8):1427\u201341. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.11.002.","journal-title":"Biotechnol Adv"},{"issue":"3","key":"2558_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/17460441.2019.1570129","volume":"14","author":"M Zanoni","year":"2019","unstructured":"Zanoni M, Pignatta S, Arienti C, Bonaf\u00e8 M, Tesei A. Anticancer drug discovery using multicellular tumor spheroid models. Expert Opin Drug Discov. 2019;14(3):289\u2013301. https:\/\/doi.org\/10.1080\/17460441.2019.1570129.","journal-title":"Expert Opin Drug Discov"},{"key":"2558_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2018.00006","volume":"9","author":"SA Langhans","year":"2018","unstructured":"Langhans SA. Three-Dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol. 2018;9:6. https:\/\/doi.org\/10.3389\/fphar.2018.00006.","journal-title":"Front Pharmacol"},{"issue":"12","key":"2558_CR61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tcb.2011.09.005","volume":"21","author":"D Huh","year":"2011","unstructured":"Huh D, Hamilton GA, Ingber DE. From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011;21(12):745\u201354. https:\/\/doi.org\/10.1016\/j.tcb.2011.09.005.","journal-title":"Trends Cell Biol"},{"key":"2558_CR62","doi-asserted-by":"publisher","unstructured":"Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D cell culture systems: tumor Application, Advantages, and disadvantages. Int J Mol Sci. 2021;22(22). https:\/\/doi.org\/10.3390\/ijms222212200.","DOI":"10.3390\/ijms222212200"},{"issue":"3","key":"2558_CR63","doi-asserted-by":"publisher","first-page":"e10627","DOI":"10.1002\/btm2.10627","volume":"9","author":"H Ryoo","year":"2024","unstructured":"Ryoo H, Kimmel H, Rondo E, Underhill GH. Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications. Bioeng Translational Med. 2024;9(3):e10627. https:\/\/doi.org\/10.1002\/btm2.10627.","journal-title":"Bioeng Translational Med"},{"issue":"4","key":"2558_CR64","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1039\/c4bm00411f","volume":"3","author":"AI Neto","year":"2015","unstructured":"Neto AI, Correia CR, Oliveira MB, Rial-Hermida MI, Alvarez-Lorenzo C, Reis RL, Mano JF. A novel hanging spherical drop system for the generation of cellular spheroids and high throughput combinatorial drug screening. Biomaterials Sci. 2015;3(4):581\u20135. https:\/\/doi.org\/10.1039\/c4bm00411f.","journal-title":"Biomaterials Sci"},{"key":"2558_CR65","doi-asserted-by":"publisher","unstructured":"Costa EC, de Melo-Diogo D, Moreira AF, Carvalho MP, Correia IJ. Spheroids formation on Non-Adhesive surfaces by liquid overlay technique: considerations and practical approaches. Biotechnol J. 2018;13(1). https:\/\/doi.org\/10.1002\/biot.201700417.","DOI":"10.1002\/biot.201700417"},{"issue":"1","key":"2558_CR66","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"AS Nunes","year":"2019","unstructured":"Nunes AS, Barros AS, Costa EC, Moreira AF, Correia IJ. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng. 2019;116(1):206\u201326. https:\/\/doi.org\/10.1002\/bit.26845.","journal-title":"Biotechnol Bioeng"},{"key":"2558_CR67","doi-asserted-by":"publisher","unstructured":"Ling Z, Niego B, Li Q, Bhattaram D, Serna Villa V, Hu M, Gong Z, Smith LM, Frey BL, Ren X: Chemoselective Characterization of New Extracellular Matrix Deposition in Bioengineered Tumor Tissues. Advanced materials (Deerfield Beach, Fla) 2025, 37(47): e05445. https:\/\/doi.org\/10.1002\/adma.202505445.","DOI":"10.1002\/adma.202505445"},{"key":"2558_CR68","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biomaterials.2015.03.035","volume":"55","author":"P DelNero","year":"2015","unstructured":"DelNero P, Lane M, Verbridge SS, Kwee B, Kermani P, Hempstead B, Stroock A, Fischbach C. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways. Biomaterials. 2015;55:110\u20138. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.03.035.","journal-title":"Biomaterials"},{"issue":"3","key":"2558_CR69","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2174\/1574892810666150708110608","volume":"10","author":"M Sharma","year":"2015","unstructured":"Sharma M, Astekar M, Soi S, Manjunatha BS, Shetty DC, Radhakrishnan R. pH gradient reversal: an emerging hallmark of cancers. Recent Pat Anti-cancer Drug Discov. 2015;10(3):244\u201358. https:\/\/doi.org\/10.2174\/1574892810666150708110608.","journal-title":"Recent Pat Anti-cancer Drug Discov"},{"issue":"6","key":"2558_CR70","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/mp200292c","volume":"8","author":"JW Wojtkowiak","year":"2011","unstructured":"Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm. 2011;8(6):2032\u20138. https:\/\/doi.org\/10.1021\/mp200292c.","journal-title":"Mol Pharm"},{"issue":"7","key":"2558_CR71","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1021\/cb500132g","volume":"9","author":"S Joel","year":"2014","unstructured":"Joel S, Turner KB, Daunert S. Glucose recognition proteins for glucose sensing at physiological concentrations and temperatures. ACS Chem Biol. 2014;9(7):1595\u2013602. https:\/\/doi.org\/10.1021\/cb500132g.","journal-title":"ACS Chem Biol"},{"issue":"8","key":"2558_CR72","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6(8):583\u201392. https:\/\/doi.org\/10.1038\/nrc1893.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2558_CR73","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1096\/fj.02-0358fje","volume":"17","author":"M Wartenberg","year":"2003","unstructured":"Wartenberg M, Ling FC, M\u00fcschen M, Klein F, Acker H, Gassmann M, Petrat K, P\u00fctz V, Hescheler J, Sauer H. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2003;17(3):503\u20135. https:\/\/doi.org\/10.1096\/fj.02-0358fje.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"3","key":"2558_CR74","doi-asserted-by":"publisher","first-page":"e0194016","DOI":"10.1371\/journal.pone.0194016","volume":"13","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Wang H, Ding Q, Xing Y, Xu Z, Lu C, Luo D, Xu L, Xia W, Zhou C, et al. Establishment of patient-derived tumor spheroids for non-small cell lung cancer. PLoS ONE. 2018;13(3):e0194016. https:\/\/doi.org\/10.1371\/journal.pone.0194016.","journal-title":"PLoS ONE"},{"issue":"1","key":"2558_CR75","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.1038\/s41598-017-10863-4","volume":"7","author":"DS Reynolds","year":"2017","unstructured":"Reynolds DS, Tevis KM, Blessing WA, Colson YL, Zaman MH, Grinstaff MW. Breast cancer spheroids reveal a differential cancer stem cell response to chemotherapeutic treatment. Sci Rep. 2017;7(1):10382. https:\/\/doi.org\/10.1038\/s41598-017-10863-4.","journal-title":"Sci Rep"},{"key":"2558_CR76","doi-asserted-by":"publisher","unstructured":"Witusik-Perkowska M, Rieske P, Hu\u0142as-Bigoszewska K, Zakrzewska M, Stawski R, Kulczycka-Wojdala D, Bie\u0144kowski M, Stoczy\u0144ska-Fidelus E, Gre\u0161ner SM, Piaskowski S et al. Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies. Journal of neuro-oncology 2011, 102(3):395\u2013407. https:\/\/doi.org\/10.1007\/s11060-010-0352-0.","DOI":"10.1007\/s11060-010-0352-0"},{"issue":"1","key":"2558_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/imammb\/14.1.39","volume":"14","author":"JP Ward","year":"1997","unstructured":"Ward JP, King JR. Mathematical modelling of avascular-tumour growth. IMA J Math Appl Med Biol. 1997;14(1):39\u201369.","journal-title":"IMA J Math Appl Med Biol"},{"issue":"11\u201312","key":"2558_CR78","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/09553000701727531","volume":"83","author":"J Friedrich","year":"2007","unstructured":"Friedrich J, Ebner R, Kunz-Schughart LA. Experimental anti-tumor therapy in 3-D: spheroids\u2013old hat or new challenge? Int J Radiat Biol. 2007;83(11\u201312):849\u201371. https:\/\/doi.org\/10.1080\/09553000701727531.","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"2558_CR79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1087057104265040","volume":"9","author":"LA Kunz-Schughart","year":"2004","unstructured":"Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J BioMol Screen. 2004;9(4):273\u201385. https:\/\/doi.org\/10.1177\/1087057104265040.","journal-title":"J BioMol Screen"},{"key":"2558_CR80","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","volume":"163","author":"S Nath","year":"2016","unstructured":"Nath S, Devi GR. Three-dimensional culture systems in cancer research: focus on tumor spheroid model. Pharmacol Ther. 2016;163:94\u2013108. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.013.","journal-title":"Pharmacol Ther"},{"issue":"8","key":"2558_CR81","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/17460441.2020.1756769","volume":"15","author":"B Calpe","year":"2020","unstructured":"Calpe B, Kovacs WJ. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment. Expert Opin Drug Discov. 2020;15(8):955\u201367. https:\/\/doi.org\/10.1080\/17460441.2020.1756769.","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"2558_CR82","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ijrobp.2008.12.004","volume":"73","author":"J Russell","year":"2009","unstructured":"Russell J, Carlin S, Burke SA, Wen B, Yang KM, Ling CC. Immunohistochemical detection of changes in tumor hypoxia. Int J Radiat Oncol Biol Phys. 2009;73(4):1177\u201386. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2558_CR83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1741-7007-10-29","volume":"10","author":"M Vinci","year":"2012","unstructured":"Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D, Eccles SA. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10:29. https:\/\/doi.org\/10.1186\/1741-7007-10-29.","journal-title":"BMC Biol"},{"issue":"10","key":"2558_CR84","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1177\/1087057113499071","volume":"18","author":"CR Thoma","year":"2013","unstructured":"Thoma CR, Stroebel S, R\u00f6sch N, Calpe B, Krek W, Kelm JM. A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications. J BioMol Screen. 2013;18(10):1330\u20137. https:\/\/doi.org\/10.1177\/1087057113499071.","journal-title":"J BioMol Screen"},{"key":"2558_CR85","doi-asserted-by":"publisher","first-page":"24772","DOI":"10.1038\/srep24772","volume":"6","author":"J Wang","year":"2016","unstructured":"Wang J, Zhang X, Li X, Zhang Y, Hou T, Wei L, Qu L, Shi L, Liu Y, Zou L, et al. Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides. Sci Rep. 2016;6:24772. https:\/\/doi.org\/10.1038\/srep24772.","journal-title":"Sci Rep"},{"issue":"3","key":"2558_CR86","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1158\/1535-7163.Mct-11-0634","volume":"11","author":"F Meng","year":"2012","unstructured":"Meng F, Evans JW, Bhupathi D, Banica M, Lan L, Lorente G, Duan JX, Cai X, Mowday AM, Guise CP, et al. Molecular and cellular Pharmacology of the hypoxia-activated prodrug TH-302. Mol Cancer Ther. 2012;11(3):740\u201351. https:\/\/doi.org\/10.1158\/1535-7163.Mct-11-0634.","journal-title":"Mol Cancer Ther"},{"issue":"45","key":"2558_CR87","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904\u201312. https:\/\/doi.org\/10.1038\/onc.2008.271.","journal-title":"Oncogene"},{"issue":"6230","key":"2558_CR88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Sci (New York NY). 2015;348(6230):74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204.","journal-title":"Sci (New York NY)"},{"issue":"5","key":"2558_CR89","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, Gong Z, Zhang S, Zhou J, Cao K, et al, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761\u201373. https:\/\/doi.org\/10.7150\/jca.17648.","journal-title":"J Cancer"},{"issue":"Pt 13","key":"2558_CR90","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1242\/jcs.079509","volume":"125","author":"BM Baker","year":"2012","unstructured":"Baker BM, Chen CS. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012;125(Pt 13):3015\u201324. https:\/\/doi.org\/10.1242\/jcs.079509.","journal-title":"J Cell Sci"},{"issue":"3","key":"2558_CR91","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4(3):309\u201324. https:\/\/doi.org\/10.1038\/nprot.2008.226.","journal-title":"Nat Protoc"},{"key":"2558_CR92","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/1748-717x-8-257","volume":"8","author":"A Tesei","year":"2013","unstructured":"Tesei A, Sarnelli A, Arienti C, Menghi E, Medri L, Gabucci E, Pignatta S, Falconi M, Silvestrini R, Zoli W, et al. In vitro irradiation system for Radiobiological experiments. Radiation Oncol (London England). 2013;8:257. https:\/\/doi.org\/10.1186\/1748-717x-8-257.","journal-title":"Radiation Oncol (London England)"},{"key":"2558_CR93","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1038\/srep03462","volume":"3","author":"HF Chan","year":"2013","unstructured":"Chan HF, Zhang Y, Ho YP, Chiu YL, Jung Y, Leong KW. Rapid formation of multicellular spheroids in double-emulsion droplets with controllable microenvironment. Sci Rep. 2013;3:3462. https:\/\/doi.org\/10.1038\/srep03462.","journal-title":"Sci Rep"},{"issue":"4","key":"2558_CR94","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41591-024-02847-5","volume":"30","author":"DW McMillin","year":"2024","unstructured":"McMillin DW, Delmore J, Weisberg E, Negri JM, Geer CD, Klippel S, Mitsiades N, Schlossman RL, Munshi NC, Kung AL, et al. Author correction: tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med. 2024;30(4):1214. https:\/\/doi.org\/10.1038\/s41591-024-02847-5.","journal-title":"Nat Med"},{"key":"2558_CR95","doi-asserted-by":"publisher","first-page":"19103","DOI":"10.1038\/srep19103","volume":"6","author":"M Zanoni","year":"2016","unstructured":"Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A, Tesei A. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016;6:19103. https:\/\/doi.org\/10.1038\/srep19103.","journal-title":"Sci Rep"},{"key":"2558_CR96","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.addr.2021.02.019","volume":"172","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou J, Li Q, Li L, Jia Y, Geng F, Zhou J, Yin T. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma. Adv Drug Deliv Rev. 2021;172:80\u2013103. https:\/\/doi.org\/10.1016\/j.addr.2021.02.019.","journal-title":"Adv Drug Deliv Rev"},{"key":"2558_CR97","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036304","volume":"20","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao L, Li XF. Hypoxia and the tumor microenvironment. Technol Cancer Res Treat. 2021;20:15330338211036304. https:\/\/doi.org\/10.1177\/15330338211036304.","journal-title":"Technol Cancer Res Treat"},{"issue":"5","key":"2558_CR98","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337. https:\/\/doi.org\/10.1038\/nrc3038.","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"2558_CR99","first-page":"4373","volume":"49","author":"IF Tannock","year":"1989","unstructured":"Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989;49(16):4373\u201384.","journal-title":"Cancer Res"},{"issue":"3","key":"2558_CR100","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1381612003401046","volume":"6","author":"P Kovacic","year":"2000","unstructured":"Kovacic P, Osuna JA Jr. Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr Pharm Design. 2000;6(3):277\u2013309. https:\/\/doi.org\/10.2174\/1381612003401046.","journal-title":"Curr Pharm Design"},{"issue":"2","key":"2558_CR101","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.20596","volume":"113","author":"M Wartenberg","year":"2005","unstructured":"Wartenberg M, Gronczynska S, Bekhite MM, Saric T, Niedermeier W, Hescheler J, Sauer H. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int J Cancer. 2005;113(2):229\u201340. https:\/\/doi.org\/10.1002\/ijc.20596.","journal-title":"Int J Cancer"},{"key":"2558_CR102","doi-asserted-by":"publisher","first-page":"645460","DOI":"10.1155\/2012\/645460","volume":"2012","author":"DG Deavall","year":"2012","unstructured":"Deavall DG, Martin EA, Horner JM, Roberts R. Drug-induced oxidative stress and toxicity. J Toxicol. 2012;2012:645460. https:\/\/doi.org\/10.1155\/2012\/645460.","journal-title":"J Toxicol"},{"issue":"19","key":"2558_CR103","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","volume":"99","author":"O Tr\u00e9dan","year":"2007","unstructured":"Tr\u00e9dan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007;99(19):1441\u201354. https:\/\/doi.org\/10.1093\/jnci\/djm135.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2558_CR104","first-page":"1194","volume":"56","author":"LE Gerweck","year":"1996","unstructured":"Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 1996;56(6):1194\u20138.","journal-title":"Cancer Res"},{"issue":"9","key":"2558_CR105","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/0360-3016(85)90217-2","volume":"11","author":"AJ Thistlethwaite","year":"1985","unstructured":"Thistlethwaite AJ, Leeper DB, Moylan DJ 3rd, Nerlinger RE. pH distribution in human tumors. Int J Radiat Oncol Biol Phys. 1985;11(9):1647\u201352. https:\/\/doi.org\/10.1016\/0360-3016(85)90217-2.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2558_CR106","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0167-8140(84)80077-8","volume":"2","author":"JL Wike-Hooley","year":"1984","unstructured":"Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol. 1984;2(4):343\u201366. https:\/\/doi.org\/10.1016\/s0167-8140(84)80077-8.","journal-title":"Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol"},{"key":"2558_CR107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.actbio.2018.05.034","volume":"75","author":"LP Ferreira","year":"2018","unstructured":"Ferreira LP, Gaspar VM, Mano JF. Design of spherically structured 3D in vitro tumor models -Advances and prospects. Acta Biomater. 2018;75:11\u201334. https:\/\/doi.org\/10.1016\/j.actbio.2018.05.034.","journal-title":"Acta Biomater"},{"issue":"1","key":"2558_CR108","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1038\/s41598-019-45384-9","volume":"9","author":"M Pal","year":"2019","unstructured":"Pal M, Chen H, Lee BH, Lee JYH, Yip YS, Tan NS, Tan LP. Epithelial-mesenchymal transition of cancer cells using bioengineered hybrid scaffold composed of hydrogel\/3D-fibrous framework. Sci Rep. 2019;9(1):8997. https:\/\/doi.org\/10.1038\/s41598-019-45384-9.","journal-title":"Sci Rep"},{"issue":"3","key":"2558_CR109","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/ebc20200150","volume":"65","author":"S Shrestha","year":"2021","unstructured":"Shrestha S, Lekkala VKR, Acharya P, Siddhpura D, Lee MY. Recent advances in microarray 3D Bioprinting for high-throughput spheroid and tissue culture and analysis. Essays Biochem. 2021;65(3):481\u20139. https:\/\/doi.org\/10.1042\/ebc20200150.","journal-title":"Essays Biochem"},{"key":"2558_CR110","doi-asserted-by":"publisher","unstructured":"Banerjee D, Singh YP, Datta P, Ozbolat V, O\u2019Donnell A, Yeo M, Ozbolat IT. Strategies for 3D Bioprinting of spheroids: A comprehensive review. Biomaterials. 2022;291:121881. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121881.","DOI":"10.1016\/j.biomaterials.2022.121881"},{"issue":"12","key":"2558_CR111","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/nprot.2011.410","volume":"6","author":"KW McCracken","year":"2011","unstructured":"McCracken KW, Howell JC, Wells JM, Spence JR. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc. 2011;6(12):1920\u20138. https:\/\/doi.org\/10.1038\/nprot.2011.410.","journal-title":"Nat Protoc"},{"issue":"8","key":"2558_CR112","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ncb3200","volume":"17","author":"TK Noguchi","year":"2015","unstructured":"Noguchi TK, Ninomiya N, Sekine M, Komazaki S, Wang PC, Asashima M, Kurisaki A. Generation of stomach tissue from mouse embryonic stem cells. Nat Cell Biol. 2015;17(8):984\u201393. https:\/\/doi.org\/10.1038\/ncb3200.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2558_CR113","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.stemcr.2017.11.004","volume":"10","author":"Y Takahashi","year":"2018","unstructured":"Takahashi Y, Sato S, Kurashima Y, Yamamoto T, Kurokawa S, Yuki Y, Takemura N, Uematsu S, Lai CY, Otsu M, et al. A refined culture system for human induced pluripotent stem Cell-Derived intestinal epithelial organoids. Stem Cell Rep. 2018;10(1):314\u201328. https:\/\/doi.org\/10.1016\/j.stemcr.2017.11.004.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"2558_CR114","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.devcel.2016.08.014","volume":"38","author":"K Kretzschmar","year":"2016","unstructured":"Kretzschmar K, Clevers H. Organoids: modeling development and the stem cell niche in a dish. Dev Cell. 2016;38(6):590\u2013600. https:\/\/doi.org\/10.1016\/j.devcel.2016.08.014.","journal-title":"Dev Cell"},{"key":"2558_CR115","doi-asserted-by":"publisher","unstructured":"Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262\u20135. https:\/\/doi.org\/10.1038\/nature07935.","DOI":"10.1038\/nature07935"},{"key":"2558_CR116","doi-asserted-by":"publisher","unstructured":"Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, et al: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology. 2011;141(5):1762-72. https:\/\/doi.org\/10.1053\/j.gastro.2011.07.050.","DOI":"10.1053\/j.gastro.2011.07.050"},{"key":"2558_CR117","doi-asserted-by":"publisher","unstructured":"Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, Chan D, Chan AS, Ma S, Lam KO et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell 2018, 23(6):882\u2013e897811. https:\/\/doi.org\/10.1016\/j.stem.2018.09.016.","DOI":"10.1016\/j.stem.2018.09.016"},{"issue":"1","key":"2558_CR118","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1038\/s41467-018-05190-9","volume":"9","author":"X Li","year":"2018","unstructured":"Li X, Francies HE, Secrier M, Perner J, Miremadi A, Galeano-Dalmau N, Barendt WJ, Letchford L, Leyden GM, Goffin EK, et al. Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics. Nat Commun. 2018;9(1):2983. https:\/\/doi.org\/10.1038\/s41467-018-05190-9.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"2558_CR119","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1\u20132):324\u201338. https:\/\/doi.org\/10.1016\/j.cell.2014.12.021.","journal-title":"Cell"},{"key":"2558_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2017.02.046","volume":"54","author":"AR Murphy","year":"2017","unstructured":"Murphy AR, Laslett A, O\u2019Brien CM, Cameron NR. Scaffolds for 3D in vitro culture of neural lineage cells. Acta Biomater. 2017;54:1\u201320. https:\/\/doi.org\/10.1016\/j.actbio.2017.02.046.","journal-title":"Acta Biomater"},{"issue":"6","key":"2558_CR121","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/joa.12257","volume":"227","author":"E Knight","year":"2015","unstructured":"Knight E, Przyborski S. Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro. J Anat. 2015;227(6):746\u201356. https:\/\/doi.org\/10.1111\/joa.12257.","journal-title":"J Anat"},{"issue":"4","key":"2558_CR122","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41593-019-0350-2","volume":"22","author":"SL Giandomenico","year":"2019","unstructured":"Giandomenico SL, Mierau SB, Gibbons GM, Wenger LMD, Masullo L, Sit T, Sutcliffe M, Boulanger J, Tripodi M, Derivery E, et al. Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output. Nat Neurosci. 2019;22(4):669\u201379. https:\/\/doi.org\/10.1038\/s41593-019-0350-2.","journal-title":"Nat Neurosci"},{"issue":"34","key":"2558_CR123","doi-asserted-by":"publisher","first-page":"41361","DOI":"10.1021\/acsami.1c14650","volume":"13","author":"GM Balachander","year":"2021","unstructured":"Balachander GM, Balaji SA, Rangarajan A, Chatterjee K. Correction to enhanced metastatic potential in a 3D tissue scaffold toward a comprehensive in vitro model for breast cancer metastasis. ACS Appl Mater Interfaces. 2021;13(34):41361. https:\/\/doi.org\/10.1021\/acsami.1c14650.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2558_CR124","doi-asserted-by":"publisher","unstructured":"DiStefano TJ, Chen HY, Panebianco C, Kaya KD, Brooks MJ, Gieser L, Morgan NY, Pohida T, Swaroop A. Accelerated and improved differentiation of retinal organoids from pluripotent stem cells in Rotating-Wall vessel bioreactors. Stem Cell Rep. 2021;16(1):224. https:\/\/doi.org\/10.1016\/j.stemcr.2020.12.006.","DOI":"10.1016\/j.stemcr.2020.12.006"},{"key":"2558_CR125","doi-asserted-by":"publisher","unstructured":"Saini S, Wick TM. Concentric cylinder bioreactor for production of tissue engineered cartilage: effect of seeding density and hydrodynamic loading on construct development. Biotechnol Prog. 2003;19(2):510\u201321. https:\/\/doi.org\/10.1021\/bp0256519.","DOI":"10.1021\/bp0256519"},{"key":"2558_CR126","doi-asserted-by":"publisher","unstructured":"Park SE, Georgescu A, Huh D. Organoids-on-a-chip. Sci (New York NY). 2019;364(6444):960\u20135. https:\/\/doi.org\/10.1126\/science.aaw7894.","DOI":"10.1126\/science.aaw7894"},{"key":"2558_CR127","doi-asserted-by":"publisher","unstructured":"Shirure VS, Hughes CCW, George SC. Engineering vascularized Organoid-on-a-Chip models. Annu Rev Biomed Eng. 2021;23:141\u201367. https:\/\/doi.org\/10.1146\/annurev-bioeng-090120-094330.","DOI":"10.1146\/annurev-bioeng-090120-094330"},{"key":"2558_CR128","doi-asserted-by":"publisher","unstructured":"Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Sci (New York NY). 2014;345(6194):1247125. https:\/\/doi.org\/10.1126\/science.1247125.","DOI":"10.1126\/science.1247125"},{"key":"2558_CR129","doi-asserted-by":"publisher","unstructured":"Crespo M, Vilar E, Tsai SY, Chang K, Amin S, Srinivasan T, Zhang T, Pipalia NH, Chen HJ, Witherspoon M, et al. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat Med. 2017;23(7):878\u201384. https:\/\/doi.org\/10.1038\/nm.4355.","DOI":"10.1038\/nm.4355"},{"key":"2558_CR130","doi-asserted-by":"publisher","unstructured":"Liu L, Yu L, Li Z, Li W, Huang W: Patient-derived organoid (PDO) platforms to facilitate clinical decision making. Journal of translational medicine. 2021;19(1):40. https:\/\/doi.org\/10.1186\/s12967-020-02677-2.","DOI":"10.1186\/s12967-020-02677-2."},{"key":"2558_CR131","doi-asserted-by":"publisher","unstructured":"Zhang L, Mo S, Hu X, Ma X, Jin W, Peng DH, et al: Establishment and identification of organoids from human circulating colorectal cancer cells. Clinical and translational medicine. 2020;10(8):e247. https:\/\/doi.org\/10.1002\/ctm2.247.","DOI":"10.1002\/ctm2.247."},{"key":"2558_CR132","doi-asserted-by":"publisher","unstructured":"Wu YH, Hung YP, Chiu NC, Lee RC, Li CP, Chao Y, et al: Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma. European journal of cancer (Oxford, England : 1990). 2022;166:208-18. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.030.","DOI":"10.1016\/j.ejca.2022.01.030."},{"key":"2558_CR133","doi-asserted-by":"publisher","unstructured":"Fendler A, Bauer D, Busch J, Jung K, Wulf-Goldenberg A, Kunz S, et al: Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients. Nature communications. 2020;11(1):929. https:\/\/doi.org\/10.1038\/s41467-020-14700-7.","DOI":"10.1038\/s41467-020-14700-7."},{"key":"2558_CR134","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2014.06.005","volume":"79\u201380","author":"G Benton","year":"2014","unstructured":"Benton G, Arnaoutova I, George J, Kleinman HK, Koblinski J. Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev. 2014;79\u201380:3\u201318. https:\/\/doi.org\/10.1016\/j.addr.2014.06.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2558_CR135","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13287-020-01903-4","volume":"11","author":"K Mulfaul","year":"2020","unstructured":"Mulfaul K, Giacalone JC, Voigt AP, Riker MJ, Ochoa D, Han IC, Stone EM, Mullins RF, Tucker BA. Stepwise differentiation and functional characterization of human induced pluripotent stem cell-derived choroidal endothelial cells. Stem Cell Res Ther. 2020;11(1):409. https:\/\/doi.org\/10.1186\/s13287-020-01903-4.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"2558_CR136","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41578-019-0129-9","volume":"4","author":"MJ Kratochvil","year":"2019","unstructured":"Kratochvil MJ, Seymour AJ, Li TL, Pa\u015fca SP, Kuo CJ, Heilshorn SC. Engineered materials for organoid systems. Nat Reviews Mater. 2019;4(9):606\u201322. https:\/\/doi.org\/10.1038\/s41578-019-0129-9.","journal-title":"Nat Reviews Mater"},{"key":"2558_CR137","doi-asserted-by":"publisher","unstructured":"Morales X, Cort\u00e9s-Dom\u00ednguez I, Ortiz-de-Solorzano C. Modeling the mechanobiology of cancer cell migration using 3D biomimetic hydrogels. Gels (Basel Switzerland). 2021;7(1). https:\/\/doi.org\/10.3390\/gels7010017.","DOI":"10.3390\/gels7010017"},{"key":"2558_CR138","doi-asserted-by":"publisher","unstructured":"Huang HJ, Lee YH, Hsu YH, Liao CT, Lin YF, Chiu HW. Current strategies in assessment of nanotoxicity: alternatives to in vivo animal testing. Int J Mol Sci. 2021;22(8). https:\/\/doi.org\/10.3390\/ijms22084216.","DOI":"10.3390\/ijms22084216"},{"key":"2558_CR139","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1017\/awf.2024.39","volume":"33","author":"E Louis-Maerten","year":"2024","unstructured":"Louis-Maerten E, Rodriguez Perez C, Cajiga RM, Persson K, Elger BS. Conceptual foundations for a clarified meaning of the 3Rs principles in animal experimentation. Anim Welf (South Mimms England). 2024;33:e37. https:\/\/doi.org\/10.1017\/awf.2024.39.","journal-title":"Anim Welf (South Mimms England)"},{"issue":"3","key":"2558_CR140","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nm.3802","volume":"21","author":"M Matano","year":"2015","unstructured":"Matano M, Date S, Shimokawa M, Takano A, Fujii M, Ohta Y, Watanabe T, Kanai T, Sato T. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat Med. 2015;21(3):256\u201362. https:\/\/doi.org\/10.1038\/nm.3802.","journal-title":"Nat Med"},{"issue":"7550","key":"2558_CR141","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature14415","volume":"521","author":"J Drost","year":"2015","unstructured":"Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, Sachs N, Overmeer RM, Offerhaus GJ, Begthel H, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521(7550):43\u20137. https:\/\/doi.org\/10.1038\/nature14415.","journal-title":"Nature"},{"issue":"12","key":"2558_CR142","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s43018-024-00841-x","volume":"5","author":"T Mizutani","year":"2024","unstructured":"Mizutani T, Boretto M, Lim S, Drost J, Gonz\u00e1lez DM, Oka R, Geurts MH, Begthel H, Korving J, van Es JH, et al. Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoids. Nat Cancer. 2024;5(12):1852\u201367. https:\/\/doi.org\/10.1038\/s43018-024-00841-x.","journal-title":"Nat Cancer"},{"issue":"7964","key":"2558_CR143","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06102-8","volume":"618","author":"K Karlsson","year":"2023","unstructured":"Karlsson K, Przybilla MJ, Kotler E, Khan A, Xu H, Karagyozova K, Sockell A, Wong WH, Liu K, Mah A, et al. Deterministic evolution and stringent selection during preneoplasia. Nature. 2023;618(7964):383\u201393. https:\/\/doi.org\/10.1038\/s41586-023-06102-8.","journal-title":"Nature"},{"issue":"7936","key":"2558_CR144","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","volume":"611","author":"A Ca\u00f1ellas-Socias","year":"2022","unstructured":"Ca\u00f1ellas-Socias A, Cortina C, Hernando-Momblona X, Palomo-Ponce S, Mulholland EJ, Turon G, Mateo L, Conti S, Roman O, Sevillano M, et al. Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells. Nature. 2022;611(7936):603\u201313. https:\/\/doi.org\/10.1038\/s41586-022-05402-9.","journal-title":"Nature"},{"issue":"1","key":"2558_CR145","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s42003-025-07822-5","volume":"8","author":"S Khalili","year":"2025","unstructured":"Khalili S, Mohseninia A, Liu C, Banister CE, Heine P, Khazan M, Morrison SE, Gokare P, Cowley GS, Weir BA, et al. Comprehensive genomic dependency landscape of a human colon cancer organoid. Commun Biology. 2025;8(1):436. https:\/\/doi.org\/10.1038\/s42003-025-07822-5.","journal-title":"Commun Biology"},{"key":"2558_CR146","doi-asserted-by":"publisher","unstructured":"Sharpe BP, Nazlamova LA, Tse C, Johnston DA, Thomas J, et al: Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma. Cell reports methods. 2024;4(12):100909. https:\/\/doi.org\/10.1016\/j.crmeth.2024.100909.","DOI":"10.1016\/j.crmeth.2024.100909."},{"key":"2558_CR147","doi-asserted-by":"publisher","unstructured":"Seino T, Kawasaki S, Shimokawa M, Tamagawa H, Toshimitsu K, Fujii M, et al. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. Cell stem cell. 2018;22(3):454-67.e456. https:\/\/doi.org\/10.1016\/j.stem.2017.12.009.","DOI":"10.1016\/j.stem.2017.12.009."},{"key":"2558_CR148","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/7651_2016_10","volume":"1576","author":"HE Francies","year":"2019","unstructured":"Francies HE, Barthorpe A, McLaren-Douglas A, Barendt WJ, Garnett MJ. Drug sensitivity assays of human cancer organoid cultures. Methods Mol Biology (Clifton NJ). 2019;1576:339\u201351. https:\/\/doi.org\/10.1007\/7651_2016_10.","journal-title":"Methods Mol Biology (Clifton NJ)"},{"issue":"12","key":"2558_CR149","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","volume":"21","author":"F Vincent","year":"2022","unstructured":"Vincent F, Nueda A, Lee J, Schenone M, Prunotto M, Mercola M. Phenotypic drug discovery: recent successes, lessons learned and new directions. Nat Rev Drug Discovery. 2022;21(12):899\u2013914. https:\/\/doi.org\/10.1038\/s41573-022-00472-w.","journal-title":"Nat Rev Drug Discovery"},{"key":"2558_CR150","doi-asserted-by":"publisher","unstructured":"Fatima I, Ahmad R, Barman S, Gowrikumar S, Pravoverov K, Primeaux M, Fisher KW, Singh AB, Dhawan P. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. Br J Cancer 2024, 130(6):1046\u201358. https:\/\/doi.org\/10.1038\/s41416-023-02570-x.","DOI":"10.1038\/s41416-023-02570-x"},{"key":"2558_CR151","doi-asserted-by":"publisher","first-page":"767621","DOI":"10.3389\/fgene.2021.767621","volume":"12","author":"T Matsui","year":"2021","unstructured":"Matsui T, Shinozawa T. Human organoids for predictive toxicology research and drug development. Front Genet. 2021;12:767621. https:\/\/doi.org\/10.3389\/fgene.2021.767621.","journal-title":"Front Genet"},{"key":"2558_CR152","doi-asserted-by":"publisher","first-page":"106481","DOI":"10.1016\/j.ejps.2023.106481","volume":"188","author":"S Kourula","year":"2023","unstructured":"Kourula S, Derksen M, Jardi F, Jonkers S, van Heerden M, Verboven P, Theuns V, Van Asten S, Huybrechts T, Kunze A, et al. Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules. Eur J Pharm Sciences: Official J Eur Federation Pharm Sci. 2023;188:106481. https:\/\/doi.org\/10.1016\/j.ejps.2023.106481.","journal-title":"Eur J Pharm Sciences: Official J Eur Federation Pharm Sci"},{"issue":"7","key":"2558_CR153","doi-asserted-by":"publisher","first-page":"965","DOI":"10.20892\/j.issn.2095-3941.2021.0621","volume":"19","author":"H Li","year":"2022","unstructured":"Li H, Liu H, Chen K. Living biobank-based cancer organoids: prospects and challenges in cancer research. Cancer Biology Med. 2022;19(7):965\u201382. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2021.0621.","journal-title":"Cancer Biology Med"},{"issue":"1","key":"2558_CR154","first-page":"17","volume":"13","author":"G Botti","year":"2021","unstructured":"Botti G, Di Bonito M, Cantile M. Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety. Int J Physiol Pathophysiology Pharmacol. 2021;13(1):17\u201321.","journal-title":"Int J Physiol Pathophysiology Pharmacol"},{"key":"2558_CR155","doi-asserted-by":"publisher","first-page":"762184","DOI":"10.3389\/fonc.2021.762184","volume":"11","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Cong L, Cong X. Patient-Derived organoids in precision medicine: drug Screening, organoid-on-a-Chip and living organoid biobank. Front Oncol. 2021;11:762184. https:\/\/doi.org\/10.3389\/fonc.2021.762184.","journal-title":"Front Oncol"},{"issue":"4","key":"2558_CR156","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J, Taylor-Weiner A, Kester L, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161(4):933\u201345. https:\/\/doi.org\/10.1016\/j.cell.2015.03.053.","journal-title":"Cell"},{"issue":"6","key":"2558_CR157","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","volume":"18","author":"M Fujii","year":"2016","unstructured":"Fujii M, Shimokawa M, Date S, Takano A, Matano M, Nanki K, Ohta Y, Toshimitsu K, Nakazato Y, Kawasaki K, et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell. 2016;18(6):827\u201338. https:\/\/doi.org\/10.1016\/j.stem.2016.04.003.","journal-title":"Cell Stem Cell"},{"issue":"6378","key":"2558_CR158","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fern\u00e1ndez-Mateos J, Khan K, Lampis A, Eason K, Huntingford I, Burke R, et al. Patient-derived organoids model treatment response of metastatic Gastrointestinal cancers. Sci (New York NY). 2018;359(6378):920\u20136. https:\/\/doi.org\/10.1126\/science.aao2774.","journal-title":"Sci (New York NY)"},{"issue":"43","key":"2558_CR159","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.1073\/pnas.1516689112","volume":"112","author":"F Weeber","year":"2015","unstructured":"Weeber F, van de Wetering M, Hoogstraat M, Dijkstra KK, Krijgsman O, Kuilman T, Gadellaa-van Hooijdonk CG, van der Velden DL, Peeper DS, Cuppen EP, et al. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Proc Natl Acad Sci USA. 2015;112(43):13308\u201311. https:\/\/doi.org\/10.1073\/pnas.1516689112.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2558_CR160","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao Y, Xu X, Yang L, Zhu J, Wan J, Shen L, Xia F, Fu G, Deng Y, Pan M, et al. Patient-Derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell Stem Cell. 2020;26(1):17\u2013e2616. https:\/\/doi.org\/10.1016\/j.stem.2019.10.010.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"2558_CR161","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/nm.3973","volume":"21","author":"L Huang","year":"2015","unstructured":"Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, Nostro C, Wang R, Muthuswamy LB, Crawford HC, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21(11):1364\u201371. https:\/\/doi.org\/10.1038\/nm.3973.","journal-title":"Nat Med"},{"issue":"12","key":"2558_CR162","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarr\u00f3 LM, Bradshaw CR, Allen GE, Arnes-Benito R, Sidorova O, Gaspersz MP, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424\u201335. https:\/\/doi.org\/10.1038\/nm.4438.","journal-title":"Nat Med"},{"issue":"2","key":"2558_CR163","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/gutjnl-2017-314549","volume":"68","author":"T Seidlitz","year":"2019","unstructured":"Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Gr\u00fctzmann K, Sommer U, Schweitzer C, Sch\u00f6lch S, Uhlemann H, et al. Human gastric cancer modelling using organoids. Gut. 2019;68(2):207\u201317. https:\/\/doi.org\/10.1136\/gutjnl-2017-314549.","journal-title":"Gut"},{"key":"2558_CR164","doi-asserted-by":"publisher","unstructured":"Verissimo CS, Overmeer RM, Ponsioen B, Drost J, Mertens S, Verlaan-Klink I, Gerwen BV, van der Ven M, Wetering MV, Egan DA, et al. Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening. eLife. 2016;5. https:\/\/doi.org\/10.7554\/eLife.18489.","DOI":"10.7554\/eLife.18489"},{"issue":"6","key":"2558_CR165","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1158\/2159-8290.Cd-11-0109","volume":"1","author":"A Bertotti","year":"2011","unstructured":"Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, Cor\u00e0 D, Di Nicolantonio F, Buscarino M, Petti C, et al. A molecularly annotated platform of patient-derived xenografts (xenopatients) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov. 2011;1(6):508\u201323. https:\/\/doi.org\/10.1158\/2159-8290.Cd-11-0109.","journal-title":"Cancer Discov"},{"issue":"7","key":"2558_CR166","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nm.3585","volume":"20","author":"X Li","year":"2014","unstructured":"Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, Cantrell MA, Rack PG, Neal JT, Chan CW, et al. Oncogenic transformation of diverse Gastrointestinal tissues in primary organoid culture. Nat Med. 2014;20(7):769\u201377. https:\/\/doi.org\/10.1038\/nm.3585.","journal-title":"Nat Med"},{"key":"2558_CR167","doi-asserted-by":"publisher","unstructured":"Kim SC, Park JW, Seo HY, Kim M, Park JH, Kim GH, Lee JO, Shin YK, Bae JM, Koo BK et al. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2022, 9(5):e2103360. https:\/\/doi.org\/10.1002\/advs.202103360.","DOI":"10.1002\/advs.202103360"},{"issue":"7","key":"2558_CR168","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.stem.2023.05.012","volume":"30","author":"HHN Yan","year":"2023","unstructured":"Yan HHN, Chan AS, Lai FP, Leung SY. Organoid cultures for cancer modeling. Cell Stem Cell. 2023;30(7):917\u201337. https:\/\/doi.org\/10.1016\/j.stem.2023.05.012.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2558_CR169","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41392-020-00377-3","volume":"6","author":"J Chen","year":"2021","unstructured":"Chen J, Sun HW, Yang YY, Chen HT, Yu XJ, Wu WC, Xu YT, Jin LL, Wu XJ, Xu J, et al. Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer. Signal Transduct Target Therapy. 2021;6(1):4. https:\/\/doi.org\/10.1038\/s41392-020-00377-3.","journal-title":"Signal Transduct Target Therapy"},{"key":"2558_CR170","doi-asserted-by":"publisher","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, Liu IH, Chiou SH, Salahudeen AA, Smith AR et al. Organoid Modeling of the Tumor Immune Microenvironment. Cell 2018, 175(7):1972\u20131988.e1916. https:\/\/doi.org\/10.1016\/j.cell.2018.11.021.","DOI":"10.1016\/j.cell.2018.11.021"},{"issue":"1\u20132","key":"2558_CR171","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H, et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018;172(1\u20132):373\u2013e386310. https:\/\/doi.org\/10.1016\/j.cell.2017.11.010.","journal-title":"Cell"},{"issue":"2","key":"2558_CR172","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gendis.2019.10.012","volume":"8","author":"KL Tung","year":"2021","unstructured":"Tung KL, Chen KY, Negrete M, Chen T, Safi A, Aljamal AA, Song L, Crawford GE, Ding S, Hsu DS, et al. Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistance. Genes Dis. 2021;8(2):203\u201314. https:\/\/doi.org\/10.1016\/j.gendis.2019.10.012.","journal-title":"Genes Dis"},{"issue":"25","key":"2558_CR173","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, Galvez-Reyes J, Kalekar RL, Mulugeta N, Kapner KS, et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021;184(25):6119\u2013e61376126. https:\/\/doi.org\/10.1016\/j.cell.2021.11.017.","journal-title":"Cell"},{"issue":"3","key":"2558_CR174","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2020.10.047","volume":"160","author":"K Togasaki","year":"2021","unstructured":"Togasaki K, Sugimoto S, Ohta Y, Nanki K, Matano M, Takahashi S, Fujii M, Kanai T, Sato T. Wnt signaling shapes the histologic variation in diffuse gastric cancer. Gastroenterology. 2021;160(3):823\u201330. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.047.","journal-title":"Gastroenterology"},{"issue":"5","key":"2558_CR175","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2017.07.007","volume":"170","author":"JS Roe","year":"2017","unstructured":"Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi K, et al. Enhancer reprogramming promotes pancreatic cancer metastasis. Cell. 2017;170(5):875\u2013e888820. https:\/\/doi.org\/10.1016\/j.cell.2017.07.007.","journal-title":"Cell"},{"key":"2558_CR176","doi-asserted-by":"publisher","unstructured":"Love JR, Karthaus WR. Next-Generation modeling of cancer using organoids. Cold Spring Harbor Perspect Med. 2024;14(6). https:\/\/doi.org\/10.1101\/cshperspect.a041380.","DOI":"10.1101\/cshperspect.a041380"},{"issue":"2","key":"2558_CR177","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","volume":"21","author":"BL LeSavage","year":"2022","unstructured":"LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Next-generation cancer organoids. Nat Mater. 2022;21(2):143\u201359. https:\/\/doi.org\/10.1038\/s41563-021-01057-5.","journal-title":"Nat Mater"},{"issue":"4","key":"2558_CR178","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s43018-022-00359-0","volume":"3","author":"B Herpers","year":"2022","unstructured":"Herpers B, Eppink B, James MI, Cortina C, Ca\u00f1ellas-Socias A, Boj SF, Hernando-Momblona X, Glodzik D, Roovers RC, van de Wetering M, et al. Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR \u00d7 LGR5 bispecific antibody with efficacy in epithelial tumors. Nat Cancer. 2022;3(4):418\u201336. https:\/\/doi.org\/10.1038\/s43018-022-00359-0.","journal-title":"Nat Cancer"},{"issue":"7","key":"2558_CR179","doi-asserted-by":"publisher","first-page":"110374","DOI":"10.1016\/j.celrep.2022.110374","volume":"38","author":"P Ramesh","year":"2022","unstructured":"Ramesh P, Di Franco S, Atencia Taboada L, Zhang L, Nicotra A, Stassi G, Medema JP. BCL-XL Inhibition induces an FGFR4-mediated rescue response in colorectal cancer. Cell Rep. 2022;38(7):110374. https:\/\/doi.org\/10.1016\/j.celrep.2022.110374.","journal-title":"Cell Rep"},{"issue":"9","key":"2558_CR180","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.stemcr.2022.07.016","volume":"17","author":"Z Wang","year":"2022","unstructured":"Wang Z, Boretto M, Millen R, Natesh N, Reckzeh ES, Hsu C, Negrete M, Yao H, Quayle W, Heaton BE, et al. Rapid tissue prototyping with micro-organospheres. Stem Cell Rep. 2022;17(9):1959\u201375. https:\/\/doi.org\/10.1016\/j.stemcr.2022.07.016.","journal-title":"Stem Cell Rep"},{"issue":"12","key":"2558_CR181","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1038\/s41596-021-00494-5","volume":"16","author":"E Driehuis","year":"2021","unstructured":"Driehuis E, Kretzschmar K, Clevers H. Author correction: establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 2021;16(12):5739. https:\/\/doi.org\/10.1038\/s41596-021-00494-5.","journal-title":"Nat Protoc"},{"key":"2558_CR182","doi-asserted-by":"publisher","unstructured":"Khalili S, Patel S, Patel N, Moy V, Lyons S, Gray E, Brents R, Banister CE, Morrison SE, Buckhaults PJ. StarTrace: A Multiplex Organoid Avatar Drug Testing Platform for Personalized Medicine. bioRxiv 2025:2025.2002.2012.637574. https:\/\/doi.org\/10.1101\/2025.02.12.637574.","DOI":"10.1101\/2025.02.12.637574"},{"issue":"3","key":"2558_CR183","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.esmoop.2021.100103","volume":"6","author":"SN Ooft","year":"2021","unstructured":"Ooft SN, Weeber F, Schipper L, Dijkstra KK, McLean CM, Kaing S, van de Haar J, Prevoo W, van Werkhoven E, Snaebjornsson P, et al. Prospective experimental treatment of colorectal cancer patients based on organoid drug responses. ESMO Open. 2021;6(3):100103. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100103.","journal-title":"ESMO Open"},{"key":"2558_CR184","doi-asserted-by":"publisher","unstructured":"Ooft SN, Weeber F, Dijkstra KK, McLean CM, Kaing S, van Werkhoven E, Schipper L, Hoes L, Vis DJ, van de Haar J, et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci Transl Med. 2019;11(513). https:\/\/doi.org\/10.1126\/scitranslmed.aay2574.","DOI":"10.1126\/scitranslmed.aay2574"},{"issue":"1","key":"2558_CR185","doi-asserted-by":"publisher","first-page":"15285","DOI":"10.1038\/s41598-017-15325-5","volume":"7","author":"S Russell","year":"2017","unstructured":"Russell S, Wojtkowiak J, Neilson A, Gillies RJ. Metabolic profiling of healthy and cancerous tissues in 2D and 3D. Sci Rep. 2017;7(1):15285. https:\/\/doi.org\/10.1038\/s41598-017-15325-5.","journal-title":"Sci Rep"},{"key":"2558_CR186","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2407-13-95","volume":"13","author":"P Longati","year":"2013","unstructured":"Longati P, Jia X, Eimer J, Wagman A, Witt MR, Rehnmark S, Verbeke C, Toftg\u00e5rd R, L\u00f6hr M, Heuchel RL. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer. 2013;13:95. https:\/\/doi.org\/10.1186\/1471-2407-13-95.","journal-title":"BMC Cancer"},{"issue":"10","key":"2558_CR187","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","volume":"25","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Wu C, O\u2019Rourke KP, Szeglin BC, Zheng Y, Sauv\u00e9 CG, Adileh M, Wasserman I, Marco MR, Kim AS, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med. 2019;25(10):1607\u201314. https:\/\/doi.org\/10.1038\/s41591-019-0584-2.","journal-title":"Nat Med"},{"issue":"6","key":"2558_CR188","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S, et al. Generation of tumor-Reactive T cells by Co-culture of peripheral blood lymphocytes and tumor organoids. Cell. 2018;174(6):1586\u2013e15981512. https:\/\/doi.org\/10.1016\/j.cell.2018.07.009.","journal-title":"Cell"},{"issue":"14","key":"2558_CR189","doi-asserted-by":"publisher","first-page":"13051","DOI":"10.1007\/s00432-023-05100-7","volume":"149","author":"M Knoblauch","year":"2023","unstructured":"Knoblauch M, Ma T, Beirith I, Koch D, Hofmann F, Heinrich K, Aghamaliev U, Sirtl S, Westphalen CB, Nie\u00df H, et al. In-vitro model to mimic T cell subset change in human PDAC organoid co-culture. J Cancer Res Clin Oncol. 2023;149(14):13051\u201364. https:\/\/doi.org\/10.1007\/s00432-023-05100-7.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2558_CR190","doi-asserted-by":"publisher","unstructured":"Holokai L, Chakrabarti J, Lundy J, Croagh D, Adhikary P, Richards SS, Woodson C, Steele N, Kuester R, Scott A, et al. Murine- and Human-Derived autologous Organoid\/Immune cell Co-Cultures as Pre-Clinical models of pancreatic ductal adenocarcinoma. Cancers. 2020;12(12). https:\/\/doi.org\/10.3390\/cancers12123816.","DOI":"10.3390\/cancers12123816"},{"key":"2558_CR191","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-4939-8600-2_16","volume":"1817","author":"J Chakrabarti","year":"2018","unstructured":"Chakrabarti J, Holokai L, Syu L, Steele N, Chang J, Dlugosz A, Zavros Y. Mouse-Derived gastric organoid and immune cell Co-culture for the study of the tumor microenvironment. Methods Mol Biology (Clifton NJ). 2018;1817:157\u201368. https:\/\/doi.org\/10.1007\/978-1-4939-8600-2_16.","journal-title":"Methods Mol Biology (Clifton NJ)"},{"key":"2558_CR192","doi-asserted-by":"publisher","first-page":"1105244","DOI":"10.3389\/fimmu.2023.1105244","volume":"14","author":"B Subtil","year":"2023","unstructured":"Subtil B, Iyer KK, Poel D, Bakkerus L, Gorris MAJ, Escalona JC, van den Dries K, Cambi A, Verheul HMW, de Vries IJM, et al. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids. Front Immunol. 2023;14:1105244. https:\/\/doi.org\/10.3389\/fimmu.2023.1105244.","journal-title":"Front Immunol"},{"key":"2558_CR193","doi-asserted-by":"publisher","unstructured":"Chan IS, Ewald AJ. Organoid Co-culture Methods to Capture Cancer Cell-Natural Killer Cell Interactions. Methods in molecular biology (Clifton, NJ) 2022, 2463:235\u2013250. https:\/\/doi.org\/10.1007\/978-1-0716-2160-8_17.","DOI":"10.1007\/978-1-0716-2160-8_17"},{"issue":"1","key":"2558_CR194","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13046-023-02756-4","volume":"42","author":"S Jiang","year":"2023","unstructured":"Jiang S, Deng T, Cheng H, Liu W, Shi D, Yuan J, He Z, Wang W, Chen B, Ma L, et al. Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance. J Experimental Clin Cancer Research: CR. 2023;42(1):199. https:\/\/doi.org\/10.1186\/s13046-023-02756-4.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"4","key":"2558_CR195","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, Lopez-Yurda M, Grootscholten C, Beets GL, Snaebjornsson P, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26(4):566\u201376. https:\/\/doi.org\/10.1038\/s41591-020-0805-8.","journal-title":"Nat Med"},{"issue":"5","key":"2558_CR196","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","volume":"6","author":"M Hofer","year":"2021","unstructured":"Hofer M, Lutolf MP. Engineering organoids. Nat Reviews Mater. 2021;6(5):402\u201320. https:\/\/doi.org\/10.1038\/s41578-021-00279-y.","journal-title":"Nat Reviews Mater"},{"issue":"2","key":"2558_CR197","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","volume":"27","author":"I Vitale","year":"2021","unstructured":"Vitale I, Shema E, Loi S, Galluzzi L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med. 2021;27(2):212\u201324. https:\/\/doi.org\/10.1038\/s41591-021-01233-9.","journal-title":"Nat Med"},{"issue":"1","key":"2558_CR198","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","volume":"15","author":"CM Cattaneo","year":"2020","unstructured":"Cattaneo CM, Dijkstra KK, Fanchi LF, Kelderman S, Kaing S, van Rooij N, van den Brink S, Schumacher TN, Voest EE. Tumor organoid-T-cell coculture systems. Nat Protoc. 2020;15(1):15\u201339. https:\/\/doi.org\/10.1038\/s41596-019-0232-9.","journal-title":"Nat Protoc"},{"issue":"7702","key":"2558_CR199","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","volume":"556","author":"SF Roerink","year":"2018","unstructured":"Roerink SF, Sasaki N, Lee-Six H, Young MD, Alexandrov LB, Behjati S, Mitchell TJ, Grossmann S, Lightfoot H, Egan DA, et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature. 2018;556(7702):457\u201362. https:\/\/doi.org\/10.1038\/s41586-018-0024-3.","journal-title":"Nature"},{"issue":"4","key":"2558_CR200","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.molmed.2022.02.001","volume":"28","author":"V Bozzetti","year":"2022","unstructured":"Bozzetti V, Senger S. Organoid technologies for the study of intestinal microbiota-host interactions. Trends Mol Med. 2022;28(4):290\u2013303. https:\/\/doi.org\/10.1016\/j.molmed.2022.02.001.","journal-title":"Trends Mol Med"},{"issue":"10","key":"2558_CR201","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/s41596-021-00589-z","volume":"16","author":"J Puschhof","year":"2021","unstructured":"Puschhof J, Pleguezuelos-Manzano C, Martinez-Silgado A, Akkerman N, Saftien A, Boot C, de Waal A, Beumer J, Dutta D, Heo I, et al. Intestinal organoid cocultures with microbes. Nat Protoc. 2021;16(10):4633\u201349. https:\/\/doi.org\/10.1038\/s41596-021-00589-z.","journal-title":"Nat Protoc"},{"key":"2558_CR202","doi-asserted-by":"publisher","unstructured":"Xia Y, Whitesides GM. Soft Lithography. Angewandte Chemie (International ed in English) 1998, 37(5):550\u2013575. https:\/\/doi.org\/10.1002\/(sici)1521-3773(19980316)37:5%3C550::Aid-anie550%3E3.0.Co;2-g.","DOI":"10.1002\/(sici)1521-3773(19980316)37:5%3C550::Aid-anie550%3E3.0.Co;2-g"},{"issue":"23","key":"2558_CR203","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1021\/ac980656z","volume":"70","author":"DC Duffy","year":"1998","unstructured":"Duffy DC, McDonald JC, Schueller OJ, Whitesides GM. Rapid prototyping of microfluidic systems in Poly(dimethylsiloxane). Anal Chem. 1998;70(23):4974\u201384. https:\/\/doi.org\/10.1021\/ac980656z.","journal-title":"Anal Chem"},{"issue":"7101","key":"2558_CR204","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature05058","volume":"442","author":"GM Whitesides","year":"2006","unstructured":"Whitesides GM. The origins and the future of microfluidics. Nature. 2006;442(7101):368\u201373. https:\/\/doi.org\/10.1038\/nature05058.","journal-title":"Nature"},{"issue":"8","key":"2558_CR205","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32(8):760\u201372. https:\/\/doi.org\/10.1038\/nbt.2989.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2558_CR206","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrd4539","volume":"14","author":"EW Esch","year":"2015","unstructured":"Esch EW, Bahinski A, Huh D. Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discovery. 2015;14(4):248\u201360. https:\/\/doi.org\/10.1038\/nrd4539.","journal-title":"Nat Rev Drug Discovery"},{"issue":"12","key":"2558_CR207","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/atvbaha.123.318233","volume":"43","author":"A Shakeri","year":"2023","unstructured":"Shakeri A, Wang Y, Zhao Y, Landau S, Perera K, Lee J, Radisic M. Engineering Organ-on-a-Chip systems for vascular diseases. Arterioscler Thromb Vasc Biol. 2023;43(12):2241\u201355. https:\/\/doi.org\/10.1161\/atvbaha.123.318233.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2558_CR208","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.stem.2018.02.011","volume":"22","author":"K Ronaldson-Bouchard","year":"2018","unstructured":"Ronaldson-Bouchard K, Vunjak-Novakovic G. Organs-on-a-Chip: A fast track for engineered human tissues in drug development. Cell Stem Cell. 2018;22(3):310\u201324. https:\/\/doi.org\/10.1016\/j.stem.2018.02.011.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2558_CR209","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","volume":"20","author":"LA Low","year":"2021","unstructured":"Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. Organs-on-chips: into the next decade. Nat Rev Drug Discovery. 2021;20(5):345\u201361. https:\/\/doi.org\/10.1038\/s41573-020-0079-3.","journal-title":"Nat Rev Drug Discovery"},{"issue":"4","key":"2558_CR210","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1021\/cr300337x","volume":"113","author":"PN Nge","year":"2013","unstructured":"Nge PN, Rogers CI, Woolley AT. Advances in microfluidic materials, functions, integration, and applications. Chem Rev. 2013;113(4):2550\u201383. https:\/\/doi.org\/10.1021\/cr300337x.","journal-title":"Chem Rev"},{"key":"2558_CR211","doi-asserted-by":"publisher","unstructured":"Tsao CW. Polymer microfluidics: Simple, Low-Cost fabrication process bridging academic lab research to commercialized production. Micromachines. 2016;7(12). https:\/\/doi.org\/10.3390\/mi7120225.","DOI":"10.3390\/mi7120225"},{"issue":"3","key":"2558_CR212","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/polym4031349","volume":"4","author":"A Alrifaiy","year":"2012","unstructured":"Alrifaiy A, Lindahl OA, Ramser K. Polymer-based microfluidic devices for pharmacy, biology and tissue engineering. Polymers. 2012;4(3):1349\u201398.","journal-title":"Polymers"},{"key":"2558_CR213","doi-asserted-by":"publisher","unstructured":"Bor\u00f3k A, Laboda K, Bony\u00e1r A. PDMS bonding technologies for microfluidic applications: A review. Biosensors. 2021;11(8). https:\/\/doi.org\/10.3390\/bios11080292.","DOI":"10.3390\/bios11080292"},{"key":"2558_CR214","doi-asserted-by":"publisher","unstructured":"Shakeri A, Khan S, Jarad NA, Didar TF. The fabrication and bonding of thermoplastic microfluidics: A review. Mater (Basel Switzerland). 2022;15(18). https:\/\/doi.org\/10.3390\/ma15186478.","DOI":"10.3390\/ma15186478"},{"issue":"6","key":"2558_CR215","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1039\/c7lc01084b","volume":"18","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang L, Zhu Y, Qin J. Human brain organoid-on-a-chip to model prenatal nicotine exposure. Lab Chip. 2018;18(6):851\u201360. https:\/\/doi.org\/10.1039\/c7lc01084b.","journal-title":"Lab Chip"},{"key":"2558_CR216","doi-asserted-by":"publisher","unstructured":"Workman MJ, Gleeson JP, Troisi EJ, Estrada HQ, Kerns SJ, Hinojosa CD, Hamilton GA, Targan SR, Svendsen CN, Barrett RJ. Enhanced utilization of induced pluripotent stem Cell-Derived human intestinal organoids using microengineered chips. Cell Mol Gastroenterol Hepatol 2018, 5(4):669\u2013e677662. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.12.008.","DOI":"10.1016\/j.jcmgh.2017.12.008"},{"issue":"23","key":"2558_CR217","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1039\/c8lc00869h","volume":"18","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang H, Deng P, Chen W, Guo Y, Tao T, Qin J. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab Chip. 2018;18(23):3606\u201316. https:\/\/doi.org\/10.1039\/c8lc00869h.","journal-title":"Lab Chip"},{"key":"2558_CR218","doi-asserted-by":"publisher","unstructured":"Zhang YS, Arneri A, Bersini S, Shin SR, Zhu K, Goli-Malekabadi Z, Aleman J, Colosi C, Busignani F, Dell\u2019Erba V et al. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials 2016, 110:45\u201359. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.09.003.","DOI":"10.1016\/j.biomaterials.2016.09.003"},{"issue":"1","key":"2558_CR219","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1038\/s41598-018-21200-8","volume":"8","author":"AR Mazzocchi","year":"2018","unstructured":"Mazzocchi AR, Rajan SAP, Votanopoulos KI, Hall AR, Skardal A. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening. Sci Rep. 2018;8(1):2886. https:\/\/doi.org\/10.1038\/s41598-018-21200-8.","journal-title":"Sci Rep"},{"issue":"12","key":"2558_CR220","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1093\/nar\/gky030","volume":"46","author":"B Laperrousaz","year":"2018","unstructured":"Laperrousaz B, Porte S, Gerbaud S, H\u00e4rm\u00e4 V, Kermarrec F, Hourtane V, Bottausci F, Gidrol X. Picollet-D\u2019hahan N: direct transfection of clonal organoids in matrigel microbeads: a promising approach toward organoid-based genetic screens. Nucleic Acids Res. 2018;46(12):e70. https:\/\/doi.org\/10.1093\/nar\/gky030.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2558_CR221","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/bit.26341","volume":"114","author":"LJY Ong","year":"2017","unstructured":"Ong LJY, Chong LH, Jin L, Singh PK, Lee PS, Yu H, Ananthanarayanan A, Leo HL, Toh YC. A pump-free microfluidic 3D perfusion platform for the efficient differentiation of human hepatocyte-like cells. Biotechnol Bioeng. 2017;114(10):2360\u201370. https:\/\/doi.org\/10.1002\/bit.26341.","journal-title":"Biotechnol Bioeng"},{"key":"2558_CR222","doi-asserted-by":"publisher","unstructured":"Wang X, Zhao D, Phan DTT, Liu J, Chen X, Yang B, Hughes CCW, Zhang W, Lee AP. A hydrostatic pressure-driven passive micropump enhanced with siphon-based autofill function. Lab Chip 2018, 18(15):2167\u201377. https:\/\/doi.org\/10.1039\/c8lc00236c.","DOI":"10.1039\/c8lc00236c"},{"issue":"6","key":"2558_CR223","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1039\/c3lc51205c","volume":"14","author":"D Welch","year":"2014","unstructured":"Welch D, Christen JB. Real-time feedback control of pH within microfluidics using integrated sensing and actuation. Lab Chip. 2014;14(6):1191\u20137. https:\/\/doi.org\/10.1039\/c3lc51205c.","journal-title":"Lab Chip"},{"issue":"4","key":"2558_CR224","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1021\/acsomega.9b00064","volume":"4","author":"P Gimenez-Gomez","year":"2019","unstructured":"Gimenez-Gomez P, Fernandez-Sanchez C, Baldi A. Microfluidic modules with integrated solid-state sensors for reconfigurable miniaturized analysis systems. ACS Omega. 2019;4(4):6192\u20138.","journal-title":"ACS Omega"},{"key":"2558_CR225","doi-asserted-by":"publisher","first-page":"127623","DOI":"10.1016\/j.talanta.2025.127623","volume":"287","author":"MM Elhassan","year":"2025","unstructured":"Elhassan MM, Mahmoud AM, Hegazy MA, Mowaka S, Bell JG. New trends in potentiometric sensors: from design to clinical and biomedical applications. Talanta. 2025;287:127623. https:\/\/doi.org\/10.1016\/j.talanta.2025.127623.","journal-title":"Talanta"},{"issue":"3","key":"2558_CR226","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/bios5030513","volume":"5","author":"SM Bonk","year":"2015","unstructured":"Bonk SM, Stubbe M, Buehler SM, Tautorat C, Baumann W, Klinkenberg ED, Gimsa J. Design and characterization of a sensorized microfluidic cell-Culture system with Electro-Thermal Micro-Pumps and sensors for cell Adhesion, Oxygen, and pH on a glass chip. Biosensors. 2015;5(3):513\u201336. https:\/\/doi.org\/10.3390\/bios5030513.","journal-title":"Biosensors"},{"issue":"2","key":"2558_CR227","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.snb.2007.03.017","volume":"125","author":"C-C Wu","year":"2007","unstructured":"Wu C-C, Saito T, Yasukawa T, Shiku H, Abe H, Hoshi H, Matsue T. Microfluidic chip integrated with amperometric detector array for in situ estimating oxygen consumption characteristics of single bovine embryos. Sens Actuators B. 2007;125(2):680\u20137.","journal-title":"Sens Actuators B"},{"issue":"4","key":"2558_CR228","doi-asserted-by":"publisher","first-page":"044111","DOI":"10.1063\/1.4955155","volume":"10","author":"SA Mousavi Shaegh","year":"2016","unstructured":"Mousavi Shaegh SA, De Ferrari F, Zhang YS, Nabavinia M, Binth Mohammad N, Ryan J, Pourmand A, Laukaitis E, Banan Sadeghian R, Nadhman A, et al. A microfluidic optical platform for real-time monitoring of pH and oxygen in microfluidic bioreactors and organ-on-chip devices. Biomicrofluidics. 2016;10(4):044111. https:\/\/doi.org\/10.1063\/1.4955155.","journal-title":"Biomicrofluidics"},{"issue":"12","key":"2558_CR229","doi-asserted-by":"publisher","first-page":"E2293","DOI":"10.1073\/pnas.1612906114","volume":"114","author":"YS Zhang","year":"2017","unstructured":"Zhang YS, Aleman J, Shin SR, Kilic T, Kim D, Mousavi Shaegh SA, Massa S, Riahi R, Chae S, Hu N, et al. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc Natl Acad Sci USA. 2017;114(12):E2293\u2013302. https:\/\/doi.org\/10.1073\/pnas.1612906114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2558_CR230","doi-asserted-by":"publisher","unstructured":"Duzagac F, Saorin G, Memeo L, Canzonieri V, Rizzolio F. Microfluidic Organoids-on-a-Chip: quantum leap in cancer research. Cancers. 2021;13(4). https:\/\/doi.org\/10.3390\/cancers13040737.","DOI":"10.3390\/cancers13040737"},{"issue":"48","key":"2558_CR231","doi-asserted-by":"publisher","first-page":"18886","DOI":"10.1073\/pnas.0610868104","volume":"104","author":"D Huh","year":"2007","unstructured":"Huh D, Fujioka H, Tung YC, Futai N, Paine R 3rd, Grotberg JB, Takayama S. Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems. Proc Natl Acad Sci USA. 2007;104(48):18886\u201391. https:\/\/doi.org\/10.1073\/pnas.0610868104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2558_CR232","doi-asserted-by":"publisher","unstructured":"Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Sci (New York NY). 2010;328(5986):1662\u20138. https:\/\/doi.org\/10.1126\/science.1188302.","DOI":"10.1126\/science.1188302"},{"key":"2558_CR233","doi-asserted-by":"publisher","unstructured":"Jang KJ, Otieno MA, Ronxhi J, Lim HK, Ewart L, Kodella KR, Petropolis DB, Kulkarni G, Rubins JE, Conegliano D, et al. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci Transl Med. 2019;11(517). https:\/\/doi.org\/10.1126\/scitranslmed.aax5516.","DOI":"10.1126\/scitranslmed.aax5516"},{"issue":"3","key":"2558_CR234","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1021\/acs.analchem.5b03869","volume":"88","author":"C Ma","year":"2016","unstructured":"Ma C, Zhao L, Zhou EM, Xu J, Shen S, Wang J. On-Chip construction of liver Lobule-like microtissue and its application for adverse drug reaction assay. Anal Chem. 2016;88(3):1719\u201327. https:\/\/doi.org\/10.1021\/acs.analchem.5b03869.","journal-title":"Anal Chem"},{"issue":"14","key":"2558_CR235","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1039\/c6lc00540c","volume":"16","author":"C Ma","year":"2016","unstructured":"Ma C, Tian C, Zhao L, Wang J. Pneumatic-aided micro-molding for flexible fabrication of homogeneous and heterogeneous cell-laden microgels. Lab Chip. 2016;16(14):2609\u201317. https:\/\/doi.org\/10.1039\/c6lc00540c.","journal-title":"Lab Chip"},{"issue":"1","key":"2558_CR236","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1038\/s41467-019-11178-w","volume":"10","author":"K Shik Mun","year":"2019","unstructured":"Shik Mun K, Arora K, Huang Y, Yang F, Yarlagadda S, Ramananda Y, Abu-El-Haija M, Palermo JJ, Appakalai BN, Nathan JD, et al. Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders. Nat Commun. 2019;10(1):3124. https:\/\/doi.org\/10.1038\/s41467-019-11178-w.","journal-title":"Nat Commun"},{"issue":"18","key":"2558_CR237","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1039\/c9lc00253g","volume":"19","author":"AL Glieberman","year":"2019","unstructured":"Glieberman AL, Pope BD, Zimmerman JF, Liu Q, Ferrier JP, Kenty JHR, Schrell AM, Mukhitov N, Shores KL, Tepole AB, et al. Synchronized stimulation and continuous insulin sensing in a microfluidic human islet on a chip designed for scalable manufacturing. Lab Chip. 2019;19(18):2993\u20133010. https:\/\/doi.org\/10.1039\/c9lc00253g.","journal-title":"Lab Chip"},{"issue":"2","key":"2558_CR238","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10544-017-0179-y","volume":"19","author":"KY Shim","year":"2017","unstructured":"Shim KY, Lee D, Han J, Nguyen NT, Park S, Sung JH. Microfluidic gut-on-a-chip with three-dimensional villi structure. Biomed Microdevices. 2017;19(2):37. https:\/\/doi.org\/10.1007\/s10544-017-0179-y.","journal-title":"Biomed Microdevices"},{"issue":"7","key":"2558_CR239","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41551-019-0397-0","volume":"3","author":"S Jalili-Firoozinezhad","year":"2019","unstructured":"Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, Camacho DM, Fadel CW, Bein A, Swenor B, Nestor B, Cronce MJ, Tovaglieri A, et al. A complex human gut Microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomedical Eng. 2019;3(7):520\u201331. https:\/\/doi.org\/10.1038\/s41551-019-0397-0.","journal-title":"Nat Biomedical Eng"},{"issue":"12","key":"2558_CR240","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/aor.13163","volume":"42","author":"Y Guo","year":"2018","unstructured":"Guo Y, Li Z, Su W, Wang L, Zhu Y, Qin J. A biomimetic human Gut-on-a-Chip for modeling drug metabolism in intestine. Artif Organs. 2018;42(12):1196\u2013205. https:\/\/doi.org\/10.1111\/aor.13163.","journal-title":"Artif Organs"},{"issue":"4","key":"2558_CR241","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1039\/c9lc00861f","volume":"20","author":"CP Pires de Mello","year":"2020","unstructured":"Pires de Mello CP, Carmona-Moran C, McAleer CW, Perez J, Coln EA, Long CJ, Oleaga C, Riu A, Note R, Teissier S, et al. Microphysiological heart-liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery. Lab Chip. 2020;20(4):749\u201359. https:\/\/doi.org\/10.1039\/c9lc00861f.","journal-title":"Lab Chip"},{"issue":"12","key":"2558_CR242","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1039\/c5lc00392j","volume":"15","author":"I Maschmeyer","year":"2015","unstructured":"Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T, Ramme AP, H\u00fcbner J, Lindner M, Drewell C, Bauer S, Thomas A, et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip. 2015;15(12):2688\u201399. https:\/\/doi.org\/10.1039\/c5lc00392j.","journal-title":"Lab Chip"},{"issue":"4","key":"2558_CR243","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1039\/c4ib00292j","volume":"7","author":"HE Abaci","year":"2015","unstructured":"Abaci HE, Shuler ML. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics\/pharmacodynamics modeling. Integr Biology: Quant Biosci Nano Macro. 2015;7(4):383\u201391. https:\/\/doi.org\/10.1039\/c4ib00292j.","journal-title":"Integr Biology: Quant Biosci Nano Macro"},{"key":"2558_CR244","doi-asserted-by":"publisher","unstructured":"Zhang C, Zhao Z, Abdul Rahim NA, van Noort D, Yu H. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip 2009, 9(22):3185\u201392. https:\/\/doi.org\/10.1039\/b915147h.","DOI":"10.1039\/b915147h"},{"issue":"1","key":"2558_CR245","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1021\/acs.analchem.8b05293","volume":"91","author":"JH Sung","year":"2019","unstructured":"Sung JH, Wang YI, Narasimhan Sriram N, Jackson M, Long C, Hickman JJ, Shuler ML. Recent advances in Body-on-a-Chip systems. Anal Chem. 2019;91(1):330\u201351. https:\/\/doi.org\/10.1021\/acs.analchem.8b05293.","journal-title":"Anal Chem"},{"issue":"10","key":"2558_CR246","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/bit.25989","volume":"113","author":"PG Miller","year":"2016","unstructured":"Miller PG, Shuler ML. Design and demonstration of a pumpless 14 compartment microphysiological system. Biotechnol Bioeng. 2016;113(10):2213\u201327. https:\/\/doi.org\/10.1002\/bit.25989.","journal-title":"Biotechnol Bioeng"},{"key":"2558_CR247","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s42003-019-0305-x","volume":"2","author":"N Phan","year":"2019","unstructured":"Phan N, Hong JJ, Tofig B, Mapua M, Elashoff D, Moatamed NA, Huang J, Memarzadeh S, Damoiseaux R, Soragni A. A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids. Commun Biology. 2019;2:78. https:\/\/doi.org\/10.1038\/s42003-019-0305-x.","journal-title":"Commun Biology"},{"key":"2558_CR248","doi-asserted-by":"publisher","first-page":"771173","DOI":"10.3389\/fonc.2021.771173","volume":"11","author":"ER Spiller","year":"2021","unstructured":"Spiller ER, Ung N, Kim S, Patsch K, Lau R, Strelez C, Doshi C, Choung S, Choi B, Juarez Rosales EF, et al. Imaging-Based machine learning analysis of Patient-Derived tumor organoid drug response. Front Oncol. 2021;11:771173. https:\/\/doi.org\/10.3389\/fonc.2021.771173.","journal-title":"Front Oncol"},{"issue":"4","key":"2558_CR249","doi-asserted-by":"publisher","first-page":"109429","DOI":"10.1016\/j.celrep.2021.109429","volume":"36","author":"BM Larsen","year":"2021","unstructured":"Larsen BM, Kannan M, Langer LF, Leibowitz BD, Bentaieb A, Cancino A, Dolgalev I, Drummond BE, Dry JR, Ho CS, et al. A pan-cancer organoid platform for precision medicine. Cell Rep. 2021;36(4):109429. https:\/\/doi.org\/10.1016\/j.celrep.2021.109429.","journal-title":"Cell Rep"},{"issue":"1","key":"2558_CR250","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1038\/s41467-021-26081-6","volume":"12","author":"S Khan","year":"2021","unstructured":"Khan S, Shin JH, Ferri V, Cheng N, Noel JE, Kuo C, Sunwoo JB, Pratx G. High-resolution positron emission microscopy of patient-derived tumor organoids. Nat Commun. 2021;12(1):5883. https:\/\/doi.org\/10.1038\/s41467-021-26081-6.","journal-title":"Nat Commun"},{"issue":"52","key":"2558_CR251","doi-asserted-by":"publisher","first-page":"14915","DOI":"10.1073\/pnas.1609569114","volume":"113","author":"YY Chen","year":"2016","unstructured":"Chen YY, Silva PN, Syed AM, Sindhwani S, Rocheleau JV, Chan WC. Clarifying intact 3D tissues on a microfluidic chip for high-throughput structural analysis. Proc Natl Acad Sci USA. 2016;113(52):14915\u201320. https:\/\/doi.org\/10.1073\/pnas.1609569114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2558_CR252","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1177\/2472555220929291","volume":"25","author":"J Wardwell-Swanson","year":"2020","unstructured":"Wardwell-Swanson J, Suzuki M, Dowell KG, Bieri M, Thoma EC, Agarkova I, Chiovaro F, Strebel S, Buschmann N, Greve F, et al. A framework for optimizing High-Content imaging of 3D models for drug discovery. SLAS Discovery: Adv Life Sci R D. 2020;25(7):709\u201322. https:\/\/doi.org\/10.1177\/2472555220929291.","journal-title":"SLAS Discovery: Adv Life Sci R D"},{"issue":"3","key":"2558_CR253","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.tibtech.2018.08.005","volume":"37","author":"J Riordon","year":"2019","unstructured":"Riordon J, Sovilj D, Sanner S, Sinton D, Young EWK. Deep learning with microfluidics for biotechnology. Trends Biotechnol. 2019;37(3):310\u201324. https:\/\/doi.org\/10.1016\/j.tibtech.2018.08.005.","journal-title":"Trends Biotechnol"},{"issue":"26","key":"2558_CR254","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1039\/C8AY00970H","volume":"10","author":"X Li","year":"2018","unstructured":"Li X, Tian T. Recent advances in an organ-on-a-chip: biomarker analysis and applications. Anal Methods. 2018;10(26):3122\u201330.","journal-title":"Anal Methods"},{"issue":"1","key":"2558_CR255","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1038\/s41467-020-19058-4","volume":"11","author":"B Schuster","year":"2020","unstructured":"Schuster B, Junkin M, Kashaf SS, Romero-Calvo I, Kirby K, Matthews J, Weber CR, Rzhetsky A, White KP, Tay S. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nat Commun. 2020;11(1):5271. https:\/\/doi.org\/10.1038\/s41467-020-19058-4.","journal-title":"Nat Commun"},{"key":"2558_CR256","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41378-022-00370-6","volume":"8","author":"MR Haque","year":"2022","unstructured":"Haque MR, Wessel CR, Leary DD, Wang C, Bhushan A, Bishehsari F. Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment. Microsystems Nanoengineering. 2022;8:36. https:\/\/doi.org\/10.1038\/s41378-022-00370-6.","journal-title":"Microsystems Nanoengineering"},{"key":"2558_CR257","doi-asserted-by":"publisher","unstructured":"Jang M, Koh I, Lee SJ, Cheong JH, Kim P. Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells. Sci Rep 2017, 7:41541. https:\/\/doi.org\/10.1038\/srep41541.","DOI":"10.1038\/srep41541"},{"issue":"11","key":"2558_CR258","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2013.137","volume":"8","author":"D Huh","year":"2013","unstructured":"Huh D, Kim HJ, Fraser JP, Shea DE, Khan M, Bahinski A, Hamilton GA, Ingber DE. Microfabrication of human organs-on-chips. Nat Protoc. 2013;8(11):2135\u201357. https:\/\/doi.org\/10.1038\/nprot.2013.137.","journal-title":"Nat Protoc"},{"issue":"8","key":"2558_CR259","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.tibtech.2021.01.004","volume":"39","author":"S Jalili-Firoozinezhad","year":"2021","unstructured":"Jalili-Firoozinezhad S, Miranda CC, Cabral JMS. Modeling the human body on microfluidic chips. Trends Biotechnol. 2021;39(8):838\u201352. https:\/\/doi.org\/10.1016\/j.tibtech.2021.01.004.","journal-title":"Trends Biotechnol"},{"key":"2558_CR260","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-010716-104748","volume":"58","author":"R Prantil-Baun","year":"2018","unstructured":"Prantil-Baun R, Novak R, Das D, Somayaji MR, Przekwas A, Ingber DE. Physiologically based Pharmacokinetic and pharmacodynamic analysis enabled by microfluidically linked Organs-on-Chips. Annu Rev Pharmacol Toxicol. 2018;58:37\u201364. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010716-104748.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"2558_CR261","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cmet.2019.02.003","volume":"29","author":"L Mancio-Silva","year":"2019","unstructured":"Mancio-Silva L, Fleming HE, Miller AB, Milstein S, Liebow A, Haslett P, Sepp-Lorenzino L, Bhatia SN. Improving drug discovery by nucleic acid delivery in engineered human microlivers. Cell Metabol. 2019;29(3):727\u2013e735723. https:\/\/doi.org\/10.1016\/j.cmet.2019.02.003.","journal-title":"Cell Metabol"},{"issue":"1","key":"2558_CR262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","volume":"21","author":"OA Almazroo","year":"2017","unstructured":"Almazroo OA, Miah MK, Venkataramanan R. Drug metabolism in the liver. Clin Liver Dis. 2017;21(1):1\u201320. https:\/\/doi.org\/10.1016\/j.cld.2016.08.001.","journal-title":"Clin Liver Dis"},{"key":"2558_CR263","doi-asserted-by":"publisher","first-page":"107831","DOI":"10.1016\/j.bej.2020.107831","volume":"165","author":"P-Y Chen","year":"2021","unstructured":"Chen P-Y, Hsieh M-J, Liao Y-H, Lin Y-C, Hou Y-T. Liver-on-a-chip platform to study anticancer effect of Statin and its metabolites. Biochem Eng J. 2021;165:107831. https:\/\/doi.org\/10.1016\/j.bej.2020.107831.","journal-title":"Biochem Eng J"},{"issue":"1","key":"2558_CR264","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","volume":"2","author":"L Ewart","year":"2022","unstructured":"Ewart L, Apostolou A, Briggs SA, Carman CV, Chaff JT, Heng AR, Jadalannagari S, Janardhanan J, Jang KJ, Joshipura SR, et al. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun Med. 2022;2(1):154. https:\/\/doi.org\/10.1038\/s43856-022-00209-1.","journal-title":"Commun Med"},{"issue":"9","key":"2558_CR265","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.stemcr.2021.07.016","volume":"16","author":"S Mohammadi","year":"2021","unstructured":"Mohammadi S, Morell-Perez C, Wright CW, Wyche TP, White CH, Sana TR, Lieberman LA. Assessing donor-to-donor variability in human intestinal organoid cultures. Stem Cell Rep. 2021;16(9):2364\u201378. https:\/\/doi.org\/10.1016\/j.stemcr.2021.07.016.","journal-title":"Stem Cell Rep"},{"key":"2558_CR266","doi-asserted-by":"publisher","unstructured":"Gehling K, Parekh S, Schneider F, Kirchner M, Kondylis V, Nikopoulou C, Tessarz P. RNA-sequencing of single cholangiocyte-derived organoids reveals high organoid-to organoid variability. Life Sci Alliance 2022; 5(12). https:\/\/doi.org\/10.26508\/lsa.202101340.","DOI":"10.26508\/lsa.202101340"},{"issue":"9","key":"2558_CR267","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.stemcr.2021.07.010","volume":"16","author":"M Piergiovanni","year":"2021","unstructured":"Piergiovanni M, Cangar O, Leite SB, Mian L, Jenet A, Corvi R, Whelan M, Taucer F, Ganesh A. Putting science into standards workshop on standards for organ-on-chip. Stem Cell Rep. 2021;16(9):2076\u20137. https:\/\/doi.org\/10.1016\/j.stemcr.2021.07.010.","journal-title":"Stem Cell Rep"},{"key":"2558_CR268","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.reprotox.2022.06.003","volume":"112","author":"F Pistollato","year":"2022","unstructured":"Pistollato F, Bal-Price A, Coecke S, Parvatam S, Pamies D, Czysz K, Hao J, Kee K, Teo AKK, Niu S, et al. Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells. Reproductive Toxicol (Elmsford NY). 2022;112:36\u201350. https:\/\/doi.org\/10.1016\/j.reprotox.2022.06.003.","journal-title":"Reproductive Toxicol (Elmsford NY)"},{"issue":"1","key":"2558_CR269","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-022-02719-0","volume":"21","author":"V Fosse","year":"2023","unstructured":"Fosse V, Oldoni E, Bietrix F, Budillon A, Daskalopoulos EP, Fratelli M, Gerlach B, Groenen PMA, H\u00f6lter SM, Menon JML, et al. Recommendations for robust and reproducible preclinical research in personalised medicine. BMC Med. 2023;21(1):14. https:\/\/doi.org\/10.1186\/s12916-022-02719-0.","journal-title":"BMC Med"},{"issue":"2","key":"2558_CR270","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/toxsci\/kfac061","volume":"188","author":"I Rusyn","year":"2022","unstructured":"Rusyn I, Sakolish C, Kato Y, Stephan C, Vergara L, Hewitt P, Bhaskaran V, Davis M, Hardwick RN, Ferguson SS, et al. Microphysiological systems evaluation: experience of TEX-VAL tissue chip testing consortium. Toxicol Sci. 2022;188(2):143\u201352. https:\/\/doi.org\/10.1093\/toxsci\/kfac061.","journal-title":"Toxicol Sci"},{"issue":"5","key":"2558_CR271","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1039\/d3lc00994g","volume":"24","author":"DR Reyes","year":"2024","unstructured":"Reyes DR, Esch MB, Ewart L, Nasiri R, Herland A, Sung K, Piergiovanni M, Lucchesi C, Shoemaker JT, Vukasinovic J, et al. From animal testing to in vitro systems: advancing standardization in microphysiological systems. Lab Chip. 2024;24(5):1076\u201387. https:\/\/doi.org\/10.1039\/d3lc00994g.","journal-title":"Lab Chip"},{"issue":"3","key":"2558_CR272","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0095-4543(21)00933-7","volume":"19","author":"GH Lyman","year":"1992","unstructured":"Lyman GH. Risk factors for cancer. Prim Care. 1992;19(3):465\u201379.","journal-title":"Prim Care"},{"key":"2558_CR273","doi-asserted-by":"publisher","unstructured":"Kim W, Chu TH, Nienh\u00fcser H, Jiang Z, Del Portillo A, Remotti HE, et al: PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice. Gastroenterology. 2021;160(3):781\u201396. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.036.","DOI":"10.1053\/j.gastro.2020.10.036."},{"key":"2558_CR274","doi-asserted-by":"publisher","unstructured":"Seidlitz T, Chen YT, Uhlemann H, Sch\u00f6lch S, Kochall S, Merker SR, et al: Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations. Gastroenterology. 2019;157(6):1599-614.e1592. https:\/\/doi.org\/10.1053\/j.gastro.2019.09.026.","DOI":"10.1053\/j.gastro.2019.09.026."},{"issue":"2\u20133","key":"2558_CR275","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1242\/dmm.000976","volume":"1","author":"A Richmond","year":"2008","unstructured":"Richmond A, Su Y. Mouse xenograft models vs GEM models for human cancer therapeutics. Dis Models Mech. 2008;1(2\u20133):78\u201382. https:\/\/doi.org\/10.1242\/dmm.000976.","journal-title":"Dis Models Mech"},{"issue":"1","key":"2558_CR276","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/toxsci\/kfv165","volume":"148","author":"G Ravegnini","year":"2015","unstructured":"Ravegnini G, Sammarini G, Hrelia P, Angelini S. Key genetic and epigenetic mechanisms in chemical carcinogenesis. Toxicol Sci. 2015;148(1):2\u201313. https:\/\/doi.org\/10.1093\/toxsci\/kfv165.","journal-title":"Toxicol Sci"},{"issue":"13","key":"2558_CR277","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1056\/nejm197109232851305","volume":"285","author":"HJ Ryser","year":"1971","unstructured":"Ryser HJ. Chemical carcinogenesis. N Engl J Med. 1971;285(13):721\u201334. https:\/\/doi.org\/10.1056\/nejm197109232851305.","journal-title":"N Engl J Med"},{"issue":"1","key":"2558_CR278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.etp.2013.07.001","volume":"66","author":"A Yafune","year":"2014","unstructured":"Yafune A, Taniai E, Morita R, Akane H, Kimura M, Mitsumori K, Shibutani M. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models. Experimental Toxicologic Pathology: Official J Gesellschaft Fur Toxikologische Pathologie. 2014;66(1):1\u201311. https:\/\/doi.org\/10.1016\/j.etp.2013.07.001.","journal-title":"Experimental Toxicologic Pathology: Official J Gesellschaft Fur Toxikologische Pathologie"},{"issue":"8","key":"2558_CR279","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3109\/10408444.2010.494175","volume":"40","author":"SJ Enoch","year":"2010","unstructured":"Enoch SJ, Cronin MT. A review of the electrophilic reaction chemistry involved in covalent DNA binding. Crit Rev Toxicol. 2010;40(8):728\u201348. https:\/\/doi.org\/10.3109\/10408444.2010.494175.","journal-title":"Crit Rev Toxicol"},{"issue":"2","key":"2558_CR280","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/carcin\/bgp252","volume":"31","author":"P Irigaray","year":"2010","unstructured":"Irigaray P, Belpomme D. Basic properties and molecular mechanisms of exogenous chemical carcinogens. Carcinogenesis. 2010;31(2):135\u201348. https:\/\/doi.org\/10.1093\/carcin\/bgp252.","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"2558_CR281","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/bf00343275","volume":"39","author":"H Bartsch","year":"1977","unstructured":"Bartsch H, Margison GP, Malaveille C, Camus AM, Brun G, Margison JM, Kolar GF, Wiessler M. Some aspects of metabolic activation of chemical carcinogens in relation to their organ specificity. Arch Toxicol. 1977;39(1\u20132):51\u201363. https:\/\/doi.org\/10.1007\/bf00343275.","journal-title":"Arch Toxicol"},{"key":"2558_CR282","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-1-4615-2984-2_17","volume":"61","author":"M Hirose","year":"1993","unstructured":"Hirose M, Shirai T, Takahashi S, Ogawa K, Ito N. Organ-specific modification of carcinogenesis by antioxidants in rats. Basic Life Sci. 1993;61:181\u20138. https:\/\/doi.org\/10.1007\/978-1-4615-2984-2_17.","journal-title":"Basic Life Sci"},{"issue":"12","key":"2558_CR283","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/j.1349-7006.1991.tb01800.x","volume":"82","author":"K Kawajiri","year":"1991","unstructured":"Kawajiri K, Fujii-Kuriyama Y. P450 and human cancer. Japanese J Cancer Research: Gann. 1991;82(12):1325\u201335. https:\/\/doi.org\/10.1111\/j.1349-7006.1991.tb01800.x.","journal-title":"Japanese J Cancer Research: Gann"},{"issue":"41","key":"2558_CR284","doi-asserted-by":"publisher","first-page":"11688","DOI":"10.3748\/wjg.v21.i41.11688","volume":"21","author":"L Van Der Kraak","year":"2015","unstructured":"Van Der Kraak L, Gros P, Beauchemin N. Colitis-associated colon cancer: is it in your genes? World J Gastroenterol. 2015;21(41):11688\u201399. https:\/\/doi.org\/10.3748\/wjg.v21.i41.11688.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2558_CR285","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0016-5085(94)90161-9","volume":"107","author":"TA Brentnall","year":"1994","unstructured":"Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, Burmer GC. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994;107(2):369\u201378. https:\/\/doi.org\/10.1016\/0016-5085(94)90161-9.","journal-title":"Gastroenterology"},{"key":"2558_CR286","doi-asserted-by":"publisher","first-page":"e16159","DOI":"10.7717\/peerj.16159","volume":"11","author":"D Dzhalilova","year":"2023","unstructured":"Dzhalilova D, Zolotova N, Fokichev N, Makarova O. Murine models of colorectal cancer: the azoxymethane (AOM)\/dextran sulfate sodium (DSS) model of colitis-associated cancer. PeerJ. 2023;11:e16159. https:\/\/doi.org\/10.7717\/peerj.16159.","journal-title":"PeerJ"},{"issue":"3","key":"2558_CR287","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/j.gastro.2021.05.063","volume":"161","author":"SK Murthy","year":"2021","unstructured":"Murthy SK, Feuerstein JD, Nguyen GC, Velayos FS. AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review. Gastroenterology. 2021;161(3):1043\u2013e10511044. https:\/\/doi.org\/10.1053\/j.gastro.2021.05.063.","journal-title":"Gastroenterology"},{"issue":"4564","key":"2558_CR288","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.7112116","volume":"217","author":"IJ Fidler","year":"1982","unstructured":"Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Sci (New York NY). 1982;217(4564):998\u20131003. https:\/\/doi.org\/10.1126\/science.7112116.","journal-title":"Sci (New York NY)"},{"issue":"3","key":"2558_CR289","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","volume":"170","author":"JE Talmadge","year":"2007","unstructured":"Talmadge JE, Singh RK, Fidler IJ, Raz A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol. 2007;170(3):793\u2013804. https:\/\/doi.org\/10.2353\/ajpath.2007.060929.","journal-title":"Am J Pathol"},{"issue":"10","key":"2558_CR290","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","volume":"84","author":"JI Johnson","year":"2001","unstructured":"Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer. 2001;84(10):1424\u201331. https:\/\/doi.org\/10.1054\/bjoc.2001.1796.","journal-title":"Br J Cancer"},{"issue":"9","key":"2558_CR291","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.Cd-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, M\u00e6landsmo GM, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4(9):998\u20131013. https:\/\/doi.org\/10.1158\/2159-8290.Cd-14-0001.","journal-title":"Cancer Discov"},{"issue":"7","key":"2558_CR292","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nbt.2284","volume":"30","author":"B Al-Lazikani","year":"2012","unstructured":"Al-Lazikani B, Banerji U, Workman P. Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol. 2012;30(7):679\u201392. https:\/\/doi.org\/10.1038\/nbt.2284.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"2558_CR293","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/1535-7163.Mct-06-0391","volume":"5","author":"BA Teicher","year":"2006","unstructured":"Teicher BA. Tumor models for efficacy determination. Mol Cancer Ther. 2006;5(10):2435\u201343. https:\/\/doi.org\/10.1158\/1535-7163.Mct-06-0391.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2558_CR294","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1158\/2159-8290.Cd-12-0012","volume":"2","author":"LA Garraway","year":"2012","unstructured":"Garraway LA, J\u00e4nne PA. Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov. 2012;2(3):214\u201326. https:\/\/doi.org\/10.1158\/2159-8290.Cd-12-0012.","journal-title":"Cancer Discov"},{"issue":"1","key":"2558_CR295","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","volume":"13","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13(1):4. https:\/\/doi.org\/10.1186\/s13045-019-0829-z.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"2558_CR296","first-page":"762","volume":"10","author":"A Kirschbaum","year":"1950","unstructured":"Kirschbaum A, Geisse NC, Sister TJ, Meyer LM. Effect of certain folic acid antagonists on transplanted myeloid and lymphoid leukemias of the F strain of mice. Cancer Res. 1950;10(12):762\u20138.","journal-title":"Cancer Res"},{"issue":"11","key":"2558_CR297","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.3954","volume":"21","author":"H Gao","year":"2015","unstructured":"Gao H, Korn JM, Ferretti S, Monahan JE, Wang Y, Singh M, Zhang C, Schnell C, Yang G, Zhang Y, et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med. 2015;21(11):1318\u201325. https:\/\/doi.org\/10.1038\/nm.3954.","journal-title":"Nat Med"},{"key":"2558_CR298","doi-asserted-by":"publisher","unstructured":"Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, Arcaroli JJ, Messersmith WA, Eckhardt SG. Patient-derived tumour xenografts as models for oncology drug development. Nat Reviews Clin Oncol 2012, 9(6):338\u201350. https:\/\/doi.org\/10.1038\/nrclinonc.2012.61.","DOI":"10.1038\/nrclinonc.2012.61"},{"issue":"1","key":"2558_CR299","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","volume":"20","author":"S Abdolahi","year":"2022","unstructured":"Abdolahi S, Ghazvinian Z, Muhammadnejad S, Saleh M, Asadzadeh Aghdaei H, Baghaei K. Patient-derived xenograft (PDX) models, applications and challenges in cancer research. J Translational Med. 2022;20(1):206. https:\/\/doi.org\/10.1186\/s12967-022-03405-8.","journal-title":"J Translational Med"},{"key":"2558_CR300","doi-asserted-by":"publisher","unstructured":"Okada S, Vaeteewoottacharn K, Kariya R. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models. Cells 2019, 8(8). https:\/\/doi.org\/10.3390\/cells8080889.","DOI":"10.3390\/cells8080889"},{"key":"2558_CR301","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.copbio.2020.01.003","volume":"63","author":"F Invrea","year":"2020","unstructured":"Invrea F, Rovito R, Torchiaro E, Petti C, Isella C, Medico E. Patient-derived xenografts (PDXs) as model systems for human cancer. Curr Opin Biotechnol. 2020;63:151\u20136. https:\/\/doi.org\/10.1016\/j.copbio.2020.01.003.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"2558_CR302","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2013.11.010","volume":"345","author":"HS Seol","year":"2014","unstructured":"Seol HS, Kang HJ, Lee SI, Kim NE, Kim TI, Chun SM, Kim TW, Yu CS, Suh YA, Singh SR, et al. Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor. Cancer Lett. 2014;345(1):56\u201364. https:\/\/doi.org\/10.1016\/j.canlet.2013.11.010.","journal-title":"Cancer Lett"},{"issue":"6","key":"2558_CR303","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ejca.2003.11.021","volume":"40","author":"MC Bibby","year":"2004","unstructured":"Bibby MC. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer (Oxford England: 1990). 2004;40(6):852\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2003.11.021.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"issue":"44","key":"2558_CR304","doi-asserted-by":"publisher","first-page":"71696","DOI":"10.18632\/oncotarget.12322","volume":"7","author":"Y Hiroshima","year":"2016","unstructured":"Hiroshima Y, Maawy A, Zhang Y, Zhang N, Murakami T, Chishima T, Tanaka K, Ichikawa Y, Bouvet M, Endo I, et al. Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy. Oncotarget. 2016;7(44):71696\u2013702. https:\/\/doi.org\/10.18632\/oncotarget.12322.","journal-title":"Oncotarget"},{"issue":"3","key":"2558_CR305","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1023\/a:1006140513233","volume":"17","author":"JJ Killion","year":"1998","unstructured":"Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev. 1998;17(3):279\u201384. https:\/\/doi.org\/10.1023\/a:1006140513233.","journal-title":"Cancer Metastasis Rev"},{"key":"2558_CR306","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fmed.2019.00139","volume":"6","author":"LMC Georges","year":"2019","unstructured":"Georges LMC, De Wever O, Galv\u00e1n JA, Dawson H, Lugli A, Demetter P, Zlobec I. Cell line derived xenograft mouse models are a suitable in vivo model for studying tumor budding in colorectal cancer. Front Med. 2019;6:139. https:\/\/doi.org\/10.3389\/fmed.2019.00139.","journal-title":"Front Med"},{"issue":"2","key":"2558_CR307","doi-asserted-by":"publisher","first-page":"100867","DOI":"10.1016\/j.adro.2021.100867","volume":"7","author":"TP Uccello","year":"2022","unstructured":"Uccello TP, Kintzel SA, Mills BN, Murphy JD, Garrett-Larsen J, Battaglia NG, Rodriguez CJ, Drage MG, Ye J, Love TMT, et al. Development of an orthotopic murine model of rectal cancer in conjunction with targeted Short-Course radiation therapy. Adv Radiation Oncol. 2022;7(2):100867. https:\/\/doi.org\/10.1016\/j.adro.2021.100867.","journal-title":"Adv Radiation Oncol"},{"issue":"6","key":"2558_CR308","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0023677219826165","volume":"53","author":"JP Evans","year":"2019","unstructured":"Evans JP, Winiarski BK, Sutton PA, Ressel L, Duckworth CA, Pritchard DM, Palmer DH, Goldring CE, Kitteringham NR. Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research. Lab Anim. 2019;53(6):598\u2013609. https:\/\/doi.org\/10.1177\/0023677219826165.","journal-title":"Lab Anim"},{"key":"2558_CR309","doi-asserted-by":"publisher","unstructured":"Fu XY, Besterman JM, Monosov A, Hoffman RM. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA 1991, 88(20):9345\u20139. https:\/\/doi.org\/10.1073\/pnas.88.20.9345.","DOI":"10.1073\/pnas.88.20.9345"},{"issue":"4","key":"2558_CR310","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s12253-020-00805-3","volume":"26","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhang L, Wang Q, Zheng M. Comparison of different colorectal cancer with liver metastases models using six colorectal cancer cell lines. Pathol Oncol Research: POR. 2020;26(4):2177\u201383. https:\/\/doi.org\/10.1007\/s12253-020-00805-3.","journal-title":"Pathol Oncol Research: POR"},{"issue":"1","key":"2558_CR311","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41598-017-19025-y","volume":"8","author":"RA Busuttil","year":"2018","unstructured":"Busuttil RA, Liu DS, Di Costanzo N, Schr\u00f6der J, Mitchell C, Boussioutas A. An orthotopic mouse model of gastric cancer invasion and metastasis. Sci Rep. 2018;8(1):825. https:\/\/doi.org\/10.1038\/s41598-017-19025-y.","journal-title":"Sci Rep"},{"issue":"12","key":"2558_CR312","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrc.2017.92","volume":"17","author":"N Gengenbacher","year":"2017","unstructured":"Gengenbacher N, Singhal M, Augustin HG. Preclinical mouse solid tumour models: status quo, challenges and perspectives. Nat Rev Cancer. 2017;17(12):751\u201365. https:\/\/doi.org\/10.1038\/nrc.2017.92.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2558_CR313","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ame2.12102","volume":"3","author":"RC Oliveira","year":"2020","unstructured":"Oliveira RC, Abrantes AM, Tralh\u00e3o JG, Botelho MF. The role of mouse models in colorectal cancer research-The need and the importance of the orthotopic models. Anim Models Experimental Med. 2020;3(1):1\u20138. https:\/\/doi.org\/10.1002\/ame2.12102.","journal-title":"Anim Models Experimental Med"},{"key":"2558_CR314","doi-asserted-by":"publisher","unstructured":"Chulpanova DS, Kitaeva KV, Rutland CS, Rizvanov AA, Solovyeva VV. Mouse tumor models for advanced cancer immunotherapy. Int J Mol Sci. 2020;21(11). https:\/\/doi.org\/10.3390\/ijms21114118.","DOI":"10.3390\/ijms21114118"},{"key":"2558_CR315","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.02.002","volume":"173","author":"QX Li","year":"2017","unstructured":"Li QX, Feuer G, Ouyang X, An X. Experimental animal modeling for immuno-oncology. Pharmacol Ther. 2017;173:34\u201346. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.002.","journal-title":"Pharmacol Ther"},{"key":"2558_CR316","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12935-020-01503-5","volume":"20","author":"K Nolan","year":"2020","unstructured":"Nolan K, Verzosa G, Cleaver T, Tippimanchai D, DePledge LN, Wang XJ, Young C, Le A, Doebele R, Li H, et al. Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models. Cancer Cell Int. 2020;20:417. https:\/\/doi.org\/10.1186\/s12935-020-01503-5.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"2558_CR317","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41416-020-0940-5","volume":"123","author":"TW Kim","year":"2020","unstructured":"Kim TW, Lee YS, Yun NH, Shin CH, Hong HK, Kim HH, Cho YB. MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer. Br J Cancer. 2020;123(7):1123\u201330. https:\/\/doi.org\/10.1038\/s41416-020-0940-5.","journal-title":"Br J Cancer"},{"issue":"9","key":"2558_CR318","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1242\/dmm.030403","volume":"10","author":"L G\u00f3mez-Cuadrado","year":"2017","unstructured":"G\u00f3mez-Cuadrado L, Tracey N, Ma R, Qian B, Brunton VG. Mouse models of metastasis: progress and prospects. Dis Models Mech. 2017;10(9):1061\u201374. https:\/\/doi.org\/10.1242\/dmm.030403.","journal-title":"Dis Models Mech"},{"issue":"19","key":"2558_CR319","doi-asserted-by":"publisher","first-page":"9787","DOI":"10.1158\/0008-5472.CAN-06-2396","volume":"66","author":"IJ Fidler","year":"2006","unstructured":"Fidler IJ. Models for spontaneous metastasis. Cancer Res. 2006;66(19):9787\u20139787.","journal-title":"Cancer Res"},{"issue":"118","key":"2558_CR320","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/newbio242148a0","volume":"242","author":"IJ Fidler","year":"1973","unstructured":"Fidler IJ. Selection of successive tumour lines for metastasis. Nat New Biology. 1973;242(118):148\u20139.","journal-title":"Nat New Biology"},{"issue":"8","key":"2558_CR321","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.Can-08-4210","volume":"69","author":"VC Daniel","year":"2009","unstructured":"Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M, Peacock CD, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 2009;69(8):3364\u201373. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-4210.","journal-title":"Cancer Res"},{"issue":"46","key":"2558_CR322","doi-asserted-by":"publisher","first-page":"18708","DOI":"10.1073\/pnas.1111840108","volume":"108","author":"JP Gillet","year":"2011","unstructured":"Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, et al. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci USA. 2011;108(46):18708\u201313. https:\/\/doi.org\/10.1073\/pnas.1111840108.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2558_CR323","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","volume":"163","author":"C-P Day","year":"2015","unstructured":"Day C-P, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell. 2015;163(1):39\u201353.","journal-title":"Cell"},{"issue":"1","key":"2558_CR324","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13046-016-0462-4","volume":"35","author":"L Pompili","year":"2016","unstructured":"Pompili L, Porru M, Caruso C, Biroccio A, Leonetti C. Patient-derived xenografts: a relevant preclinical model for drug development. J Experimental Clin Cancer Res. 2016;35(1):189.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"15","key":"2558_CR325","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-06-0113","volume":"12","author":"B Rubio-Viqueira","year":"2006","unstructured":"Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C, Shi C, Danenberg K, Danenberg PV, Kuramochi H. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12(15):4652\u201361.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2558_CR326","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","volume":"9","author":"JJ Tentler","year":"2012","unstructured":"Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, Arcaroli JJ, Messersmith WA, Eckhardt SG. Patient-derived tumour xenografts as models for oncology drug development. Nat Reviews Clin Oncol. 2012;9(6):338\u201350.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"8","key":"2558_CR327","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrc3972","volume":"15","author":"RM Hoffman","year":"2015","unstructured":"Hoffman RM. Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts. Nat Rev Cancer. 2015;15(8):451\u20132.","journal-title":"Nat Rev Cancer"},{"key":"2558_CR328","doi-asserted-by":"publisher","unstructured":"Zhang F, Wang W, Long Y, Liu H, Cheng J, Guo L, et al: Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response. Cancer communications (London, England). 2018;38(1):60. https:\/\/doi.org\/10.1186\/s40880-018-0329-5.","DOI":"10.1186\/s40880-018-0329-5."},{"key":"2558_CR329","doi-asserted-by":"publisher","unstructured":"Liu Z, Ahn MH, Kurokawa T, Ly A, Zhang G, Wang F, et al: A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma. Journal of translational medicine. 2020;18(1):255. https:\/\/doi.org\/10.1186\/s12967-020-02414-9.","DOI":"10.1186\/s12967-020-02414-9."},{"key":"2558_CR330","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/S0102-86502004000100010","volume":"19","author":"DJ Fagundes","year":"2004","unstructured":"Fagundes DJ, Taha MO. Modelo animal de doen\u00e7a: crit\u00e9rios de Escolha e esp\u00e9cies de animais de Uso corrente. Acta Cir\u00fargica Brasileira. 2004;19:59\u201365.","journal-title":"Acta Cir\u00fargica Brasileira"},{"key":"2558_CR331","doi-asserted-by":"crossref","unstructured":"Vdoviakov\u00e1 K, Petrovov\u00e1 E, Malovesk\u00e1 M, Kre\u0161\u00e1kov\u00e1 L, Teleky J, Elias MZJ, Petr\u00e1\u0161ov\u00e1 D. Surgical anatomy of the Gastrointestinal tract and its vasculature in the laboratory rat. Gastroenterol Res Pract 2016, 2016(1):2632368.","DOI":"10.1155\/2016\/2632368"},{"issue":"6","key":"2558_CR332","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nbt.3837","volume":"35","author":"KP O\u2019Rourke","year":"2017","unstructured":"O\u2019Rourke KP, Loizou E, Livshits G, Schatoff EM, Baslan T, Manchado E, Simon J, Romesser PB, Leach B, Han T, et al. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat Biotechnol. 2017;35(6):577\u201382. https:\/\/doi.org\/10.1038\/nbt.3837.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"2558_CR333","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.it.2018.07.001","volume":"39","author":"P De La Rochere","year":"2018","unstructured":"De La Rochere P, Guil-Luna S, Decaudin D, Azar G, Sidhu SS, Piaggio E. Humanized mice for the study of Immuno-Oncology. Trends Immunol. 2018;39(9):748\u201363. https:\/\/doi.org\/10.1016\/j.it.2018.07.001.","journal-title":"Trends Immunol"},{"key":"2558_CR334","doi-asserted-by":"publisher","unstructured":"Billerbeck E, Mommersteeg MC, Shlomai A, Xiao JW, Andrus L, Bhatta A, Vercauteren K, Michailidis E, Dorner M, Krishnan A et al. Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. J Hepatol 2016, 65(2):334\u201343. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.022.","DOI":"10.1016\/j.jhep.2016.04.022"},{"key":"2558_CR335","doi-asserted-by":"publisher","first-page":"11007","DOI":"10.1038\/ncomms11007","volume":"7","author":"B Cao","year":"2016","unstructured":"Cao B, Zhang Z, Grassinger J, Williams B, Heazlewood CK, Churches QI, James SA, Li S, Papayannopoulou T, Nilsson SK. Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist. Nat Commun. 2016;7:11007. https:\/\/doi.org\/10.1038\/ncomms11007.","journal-title":"Nat Commun"},{"key":"2558_CR336","doi-asserted-by":"publisher","unstructured":"Abarrategi A, Foster K, Hamilton A, Mian SA, Passaro D, Gribben J, Mufti G, Bonnet D. Versatile humanized niche model enables study of normal and malignant human hematopoiesis. J Clin Investig 2017, 127(2):543\u20138. https:\/\/doi.org\/10.1172\/jci89364.","DOI":"10.1172\/jci89364"},{"key":"2558_CR337","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev-immunol-032712-095921","volume":"31","author":"A Rongvaux","year":"2013","unstructured":"Rongvaux A, Takizawa H, Strowig T, Willinger T, Eynon EE, Flavell RA, Manz MG. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol. 2013;31:635\u201374. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095921.","journal-title":"Annu Rev Immunol"},{"key":"2558_CR338","doi-asserted-by":"publisher","first-page":"816956","DOI":"10.3389\/fimmu.2021.816956","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Liao S, Zhou H, Yang L, Guo F, Chen S, Li A, Pan Q, Yang C, Liu HF, et al. Humanized mouse models of systemic lupus erythematosus: opportunities and challenges. Front Immunol. 2021;12:816956. https:\/\/doi.org\/10.3389\/fimmu.2021.816956.","journal-title":"Front Immunol"},{"key":"2558_CR339","doi-asserted-by":"publisher","first-page":"677970","DOI":"10.3389\/fimmu.2021.677970","volume":"12","author":"X Yue","year":"2021","unstructured":"Yue X, Petersen F, Shu Y, Kasper B, Magatsin JDT, Ahmadi M, Yin J, Wax J, Wang X, Heidecke H, et al. Transfer of PBMC from SSc patients induces autoantibodies and systemic inflammation in Rag2-\/-\/IL2rg-\/- mice. Front Immunol. 2021;12:677970. https:\/\/doi.org\/10.3389\/fimmu.2021.677970.","journal-title":"Front Immunol"},{"key":"2558_CR340","doi-asserted-by":"publisher","unstructured":"Ehx G, Somja J, Warnatz HJ, Ritacco C, Hannon M, Delens L, Fransolet G, Delvenne P, Muller J, Beguin Y et al. Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2\/HHD Mice. Frontiers in immunology 2018, 9:1943. https:\/\/doi.org\/10.3389\/fimmu.2018.01943.","DOI":"10.3389\/fimmu.2018.01943"},{"issue":"1","key":"2558_CR341","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40425-019-0518-z","volume":"7","author":"A Capasso","year":"2019","unstructured":"Capasso A, Lang J, Pitts TM, Jordan KR, Lieu CH, Davis SL, Diamond JR, Kopetz S, Barbee J, Peterson J, et al. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts. J Immunother Cancer. 2019;7(1):37. https:\/\/doi.org\/10.1186\/s40425-019-0518-z.","journal-title":"J Immunother Cancer"},{"issue":"10","key":"2558_CR342","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1136\/gutjnl-2017-315201","volume":"67","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Shuen TWH, Toh TB, Chan XY, Liu M, Tan SY, Fan Y, Yang H, Lyer SG, Bonney GK, et al. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut. 2018;67(10):1845\u201354. https:\/\/doi.org\/10.1136\/gutjnl-2017-315201.","journal-title":"Gut"},{"issue":"6187","key":"2558_CR343","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/335256a0","volume":"335","author":"DE Mosier","year":"1988","unstructured":"Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988;335(6187):256\u20139. https:\/\/doi.org\/10.1038\/335256a0.","journal-title":"Nature"},{"issue":"3","key":"2558_CR344","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, Shultz LD, Brehm MA. Humanized mouse models for immuno-oncology research. Nat Reviews Clin Oncol. 2023;20(3):192\u2013206. https:\/\/doi.org\/10.1038\/s41571-022-00721-2.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"5","key":"2558_CR345","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/neuonc\/noab264","volume":"24","author":"E Almstedt","year":"2022","unstructured":"Almstedt E, Ros\u00e9n E, Gloger M, Stockgard R, Hekmati N, Koltowska K, Krona C, Nelander S. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts. Neurooncology. 2022;24(5):726\u201338. https:\/\/doi.org\/10.1093\/neuonc\/noab264.","journal-title":"Neurooncology"},{"issue":"39","key":"2558_CR346","doi-asserted-by":"publisher","first-page":"E8234","DOI":"10.1073\/pnas.1618389114","volume":"114","author":"R Fior","year":"2017","unstructured":"Fior R, P\u00f3voa V, Mendes RV, Carvalho T, Gomes A, Figueiredo N, Ferreira MG. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci USA. 2017;114(39):E8234\u201343. https:\/\/doi.org\/10.1073\/pnas.1618389114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2558_CR347","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2407-9-128","volume":"9","author":"IJ Marques","year":"2009","unstructured":"Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer. 2009;9:128. https:\/\/doi.org\/10.1186\/1471-2407-9-128.","journal-title":"BMC Cancer"},{"key":"2558_CR348","doi-asserted-by":"publisher","first-page":"102578","DOI":"10.1016\/j.ebiom.2019.11.039","volume":"51","author":"B Costa","year":"2020","unstructured":"Costa B, Ferreira S, P\u00f3voa V, Cardoso MJ, Vieira S, Stroom J, Fidalgo P, Rio-Tinto R, Figueiredo N, Par\u00e9s O, et al. Developments in zebrafish avatars as radiotherapy sensitivity reporters - towards personalized medicine. EBioMedicine. 2020;51:102578. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.039.","journal-title":"EBioMedicine"},{"issue":"7","key":"2558_CR349","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.trecan.2020.03.012","volume":"6","author":"J Xiao","year":"2020","unstructured":"Xiao J, Glasgow E, Agarwal S. Zebrafish xenografts for drug discovery and personalized medicine. Trends Cancer. 2020;6(7):569\u201379. https:\/\/doi.org\/10.1016\/j.trecan.2020.03.012.","journal-title":"Trends Cancer"},{"key":"2558_CR350","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fonc.2018.00400","volume":"8","author":"AF van de Merbel","year":"2018","unstructured":"van de Merbel AF, van der Horst G, van der Mark MH, van Uhm JIM, van Gennep EJ, Kloen P, Beimers L, Pelger RCM, van der Pluijm G. An ex vivo tissue culture model for the assessment of individualized drug responses in prostate and bladder cancer. Front Oncol. 2018;8:400. https:\/\/doi.org\/10.3389\/fonc.2018.00400.","journal-title":"Front Oncol"},{"issue":"7","key":"2558_CR351","doi-asserted-by":"publisher","first-page":"e1333210","DOI":"10.1080\/2162402x.2017.1333210","volume":"6","author":"X Jiang","year":"2017","unstructured":"Jiang X, Seo YD, Chang JH, Coveler A, Nigjeh EN, Pan S, Jalikis F, Yeung RS, Crispe IN, Pillarisetty VG. Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment. Oncoimmunology. 2017;6(7):e1333210. https:\/\/doi.org\/10.1080\/2162402x.2017.1333210.","journal-title":"Oncoimmunology"},{"issue":"1","key":"2558_CR352","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-017-0631-0","volume":"36","author":"JQ Wu","year":"2017","unstructured":"Wu JQ, Zhai J, Li CY, Tan AM, Wei P, Shen LZ, He MF. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. J Experimental Clin Cancer Research: CR. 2017;36(1):160. https:\/\/doi.org\/10.1186\/s13046-017-0631-0.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"2558_CR353","doi-asserted-by":"publisher","unstructured":"Di Franco G, Usai A, Funel N, Palmeri M, Montesanti IER, Bianchini M, Gianardi D, Furbetta N, Guadagni S, Vasile E et al. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine. World J Gastroenterol 2020, 26(21):2792\u2013809. https:\/\/doi.org\/10.3748\/wjg.v26.i21.2792.","DOI":"10.3748\/wjg.v26.i21.2792"},{"issue":"1","key":"2558_CR354","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1038\/s41467-021-25177-3","volume":"12","author":"H Sun","year":"2021","unstructured":"Sun H, Cao S, Mashl RJ, Mo CK, Zaccaria S, Wendl MC, Davies SR, Bailey MH, Primeau TM, Hoog J, et al. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. Nat Commun. 2021;12(1):5086. https:\/\/doi.org\/10.1038\/s41467-021-25177-3.","journal-title":"Nat Commun"},{"key":"2558_CR355","doi-asserted-by":"publisher","unstructured":"Williams JA. Using PDX for preclinical cancer drug discovery: the evolving field. J Clin Med. 2018;7(3). https:\/\/doi.org\/10.3390\/jcm7030041.","DOI":"10.3390\/jcm7030041"},{"issue":"2","key":"2558_CR356","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.Cd-11-0061","volume":"1","author":"C Nardella","year":"2011","unstructured":"Nardella C, Lunardi A, Patnaik A, Cantley LC, Pandolfi PP. The APL paradigm and the co-clinical trial project. Cancer Discov. 2011;1(2):108\u201316. https:\/\/doi.org\/10.1158\/2159-8290.Cd-11-0061.","journal-title":"Cancer Discov"},{"issue":"5","key":"2558_CR357","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrc3944","volume":"15","author":"S Aparicio","year":"2015","unstructured":"Aparicio S, Hidalgo M, Kung AL. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer. 2015;15(5):311\u20136. https:\/\/doi.org\/10.1038\/nrc3944.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2558_CR358","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/1535-7163.Mct-11-0233","volume":"10","author":"M Hidalgo","year":"2011","unstructured":"Hidalgo M, Bruckheimer E, Rajeshkumar NV, Garrido-Laguna I, De Oliveira E, Rubio-Viqueira B, Strawn S, Wick MJ, Martell J, Sidransky D. A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther. 2011;10(8):1311\u20136. https:\/\/doi.org\/10.1158\/1535-7163.Mct-11-0233.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"2558_CR359","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/pbc.21078","volume":"49","author":"PJ Houghton","year":"2007","unstructured":"Houghton PJ, Morton CL, Tucker C, Payne D, Favours E, Cole C, Gorlick R, Kolb EA, Zhang W, Lock R, et al. The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer. 2007;49(7):928\u201340. https:\/\/doi.org\/10.1002\/pbc.21078.","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"2558_CR360","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1158\/1078-0432.Ccr-07-5090","volume":"14","author":"G Neale","year":"2008","unstructured":"Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, et al. Molecular characterization of the pediatric preclinical testing panel. Clin Cancer Research: Official J Am Association Cancer Res. 2008;14(14):4572\u201383. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-5090.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"2558_CR361","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Therapy. 2023;8(1):160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","journal-title":"Signal Transduct Target Therapy"},{"issue":"20","key":"2558_CR362","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1158\/1078-0432.Ccr-18-3440","volume":"25","author":"L Lazzari","year":"2019","unstructured":"Lazzari L, Corti G, Picco G, Isella C, Montone M, Arcella P, Durinikova E, Zanella ER, Novara L, Barbosa F, et al. Patient-Derived xenografts and matched cell lines identify Pharmacogenomic vulnerabilities in colorectal cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2019;25(20):6243\u201359. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-3440.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"4","key":"2558_CR363","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/1078-0432.Ccr-17-2151","volume":"24","author":"P Luraghi","year":"2018","unstructured":"Luraghi P, Bigatto V, Cipriano E, Reato G, Orzan F, Sassi F, De Bacco F, Isella C, Bellomo SE, Medico E, et al. A molecularly annotated model of Patient-Derived colon cancer Stem-Like cells to assess genetic and nongenetic mechanisms of resistance to Anti-EGFR therapy. Clin Cancer Research: Official J Am Association Cancer Res. 2018;24(4):807\u201320. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-2151.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"2","key":"2558_CR364","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer. 2022;3(2):232\u201350. https:\/\/doi.org\/10.1038\/s43018-022-00337-6.","journal-title":"Nat Cancer"},{"key":"2558_CR365","doi-asserted-by":"publisher","unstructured":"Huang L, Bockorny B, Paul I, Akshinthala D, Frappart PO, Gandarilla O, Bose A, Sanchez-Gonzalez V, Rouse EE, Lehoux SD, et al. PDX-derived organoids model in vivo drug response and secrete biomarkers. JCI Insight. 2020;5(21). https:\/\/doi.org\/10.1172\/jci.insight.135544.","DOI":"10.1172\/jci.insight.135544"},{"key":"2558_CR366","doi-asserted-by":"publisher","unstructured":"Hassani I, Anbiah B, Kuhlers P, Habbit NL, Ahmed B, Heslin MJ, Mobley JA, Greene MW, Lipke EA. Engineered colorectal cancer tissue recapitulates key attributes of a patient-derived xenograft tumor line. Biofabrication. 2022;14(4). https:\/\/doi.org\/10.1088\/1758-5090\/ac73b6.","DOI":"10.1088\/1758-5090\/ac73b6"},{"issue":"1","key":"2558_CR367","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jnci\/djn481","volume":"101","author":"K Garber","year":"2009","unstructured":"Garber K. From human to mouse and back: \u2018tumorgraft\u2019 models surge in popularity. J Natl Cancer Inst. 2009;101(1):6\u20138. https:\/\/doi.org\/10.1093\/jnci\/djn481.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2558_CR368","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1073\/pnas.89.12.5645","volume":"89","author":"X Fu","year":"1992","unstructured":"Fu X, Guadagni F, Hoffman RM. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA. 1992;89(12):5645\u20139. https:\/\/doi.org\/10.1073\/pnas.89.12.5645.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2558_CR369","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00006676-200410000-00004","volume":"29","author":"P Loukopoulos","year":"2004","unstructured":"Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, Hirohashi S. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. Pancreas. 2004;29(3):193\u2013203. https:\/\/doi.org\/10.1097\/00006676-200410000-00004.","journal-title":"Pancreas"},{"issue":"2","key":"2558_CR370","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/clpt.2008.200","volume":"85","author":"B Rubio-Viqueira","year":"2009","unstructured":"Rubio-Viqueira B, Hidalgo M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther. 2009;85(2):217\u201321. https:\/\/doi.org\/10.1038\/clpt.2008.200.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2558_CR371","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ejca.2003.10.011","volume":"40","author":"I Fichtner","year":"2004","unstructured":"Fichtner I, Slisow W, Gill J, Becker M, Elbe B, Hillebrand T, Bibby M. Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas. Eur J Cancer (Oxford England: 1990). 2004;40(2):298\u2013307. https:\/\/doi.org\/10.1016\/j.ejca.2003.10.011.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"issue":"8","key":"2558_CR372","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1158\/0008-5472.Can-14-1590","volume":"75","author":"M Nunes","year":"2015","unstructured":"Nunes M, Vrignaud P, Vacher S, Richon S, Li\u00e8vre A, Cacheux W, Weiswald LB, Massonnet G, Chateau-Joubert S, Nicolas A, et al. Evaluating patient-derived colorectal cancer xenografts as preclinical models by comparison with patient clinical data. Cancer Res. 2015;75(8):1560\u20136. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-1590.","journal-title":"Cancer Res"},{"key":"2558_CR373","doi-asserted-by":"publisher","unstructured":"Gmeiner WH. Recent advances in therapeutic strategies to improve colorectal cancer treatment. Cancers. 2024;16(5). https:\/\/doi.org\/10.3390\/cancers16051029.","DOI":"10.3390\/cancers16051029"},{"issue":"11","key":"2558_CR374","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.ejso.2019.06.033","volume":"45","author":"W Liu","year":"2019","unstructured":"Liu W, Wang K, Han Y, Liang JY, Li YH, Xing BC. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2019;45(11):2070\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2019.06.033.","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"1","key":"2558_CR375","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-022-01622-9","volume":"21","author":"H Wang","year":"2022","unstructured":"Wang H, Yang W, Qin Q, Yang X, Yang Y, Liu H, Lu W, Gu S, Cao X, Feng D, et al. E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer. Mol Cancer. 2022;21(1):151. https:\/\/doi.org\/10.1186\/s12943-022-01622-9.","journal-title":"Mol Cancer"},{"issue":"10","key":"2558_CR376","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","volume":"19","author":"SR Punekar","year":"2022","unstructured":"Punekar SR, Velcheti V, Neel BG, Wong KK. The current state of the Art and future trends in RAS-targeted cancer therapies. Nat Reviews Clin Oncol. 2022;19(10):637\u201355. https:\/\/doi.org\/10.1038\/s41571-022-00671-9.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"14","key":"2558_CR377","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.Can-19-3682","volume":"80","author":"IA Prior","year":"2020","unstructured":"Prior IA, Hood FE, Hartley JL. The frequency of Ras mutations in cancer. Cancer Res. 2020;80(14):2969\u201374. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-3682.","journal-title":"Cancer Res"},{"issue":"11","key":"2558_CR378","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc3106","volume":"11","author":"Y Pylayeva-Gupta","year":"2011","unstructured":"Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer. 2011;11(11):761\u201374. https:\/\/doi.org\/10.1038\/nrc3106.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2558_CR379","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41467-021-22125-z","volume":"12","author":"JH Cook","year":"2021","unstructured":"Cook JH, Melloni GEM, Gulhan DC, Park PJ, Haigis KM. The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Nat Commun. 2021;12(1):1808. https:\/\/doi.org\/10.1038\/s41467-021-22125-z.","journal-title":"Nat Commun"},{"issue":"1","key":"2558_CR380","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","volume":"170","author":"DK Simanshu","year":"2017","unstructured":"Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell. 2017;170(1):17\u201333. https:\/\/doi.org\/10.1016\/j.cell.2017.06.009.","journal-title":"Cell"},{"key":"2558_CR381","doi-asserted-by":"publisher","unstructured":"Waters AM, Der CJ. KRAS: the critical driver and therapeutic target for pancreatic cancer. Cold Spring Harbor Perspect Med. 2018;8(9). https:\/\/doi.org\/10.1101\/cshperspect.a031435.","DOI":"10.1101\/cshperspect.a031435"},{"issue":"7477","key":"2558_CR382","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature12796","volume":"503","author":"JM Ostrem","year":"2013","unstructured":"Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature. 2013;503(7477):548\u201351. https:\/\/doi.org\/10.1038\/nature12796.","journal-title":"Nature"},{"issue":"25","key":"2558_CR383","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","volume":"384","author":"F Skoulidis","year":"2021","unstructured":"Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, et al. Sotorasib for lung cancers with KRAS p.G12C mutation. N Engl J Med. 2021;384(25):2371\u201381. https:\/\/doi.org\/10.1056\/NEJMoa2103695.","journal-title":"N Engl J Med"},{"issue":"4suppl","key":"2558_CR384","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1200\/JCO.2025.43.4_suppl.724","volume":"43","author":"AI Spira","year":"2025","unstructured":"Spira AI, Papadopoulos KP, Kim DW, Parikh AR, Barve MA, Powderly JD, Starodub A, Strickler JH, Li BT, Oberstein PE, et al. Preliminary safety, antitumor activity, and Circulating tumor DNA (ctDNA) changes with RMC-9805, an oral, RAS(ON) G12D-selective tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors. J Clin Oncol. 2025;43(4suppl):724\u2013724. https:\/\/doi.org\/10.1200\/JCO.2025.43.4_suppl.724.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2558_CR385","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","volume":"28","author":"J Hallin","year":"2022","unstructured":"Hallin J, Bowcut V, Calinisan A, Briere DM, Hargis L, Engstrom LD, Laguer J, Medwid J, Vanderpool D, Lifset E, et al. Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor. Nat Med. 2022;28(10):2171\u201382. https:\/\/doi.org\/10.1038\/s41591-022-02007-7.","journal-title":"Nat Med"},{"issue":"6","key":"2558_CR386","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1158\/2159-8290.Cd-24-0027","volume":"14","author":"J Jiang","year":"2024","unstructured":"Jiang J, Jiang L, Maldonato BJ, Wang Y, Holderfield M, Aronchik I, Winters IP, Salman Z, Blaj C, Menard M, et al. Translational and therapeutic evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven cancers. Cancer Discov. 2024;14(6):994\u20131017. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0027.","journal-title":"Cancer Discov"},{"key":"2558_CR387","doi-asserted-by":"publisher","first-page":"S458","DOI":"10.1016\/j.annonc.2023.09.1838","volume":"34","author":"KC Arbour","year":"2023","unstructured":"Arbour KC, Punekar S, Garrido-Laguna I, Hong DS, Wolpin B, Pelster MS, Barve M, Starodub A, Sommerhalder D, Chang S, et al. : 652O preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC). Ann Oncol. 2023;34:S458. https:\/\/doi.org\/10.1016\/j.annonc.2023.09.1838.","journal-title":"Ann Oncol"},{"issue":"8","key":"2558_CR388","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0115-0","volume":"50","author":"Y Choi","year":"2018","unstructured":"Choi Y, Lee S, Kim K, Kim SH, Chung YJ, Lee C. Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice. Exp Mol Med. 2018;50(8):1\u20139. https:\/\/doi.org\/10.1038\/s12276-018-0115-0.","journal-title":"Exp Mol Med"},{"issue":"8","key":"2558_CR389","doi-asserted-by":"publisher","first-page":"e1203498","DOI":"10.1080\/2162402x.2016.1203498","volume":"5","author":"M Bacac","year":"2016","unstructured":"Bacac M, Klein C, Umana P. CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors. Oncoimmunology. 2016;5(8):e1203498. https:\/\/doi.org\/10.1080\/2162402x.2016.1203498.","journal-title":"Oncoimmunology"},{"key":"2558_CR390","doi-asserted-by":"publisher","unstructured":"Ben-David U, Ha G, Tseng YY, Greenwald NF, Oh C, Shih J, McFarland JM, Wong B, Boehm JS, Beroukhim R et al. Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet 2017, 49(11):1567\u201375. https:\/\/doi.org\/10.1038\/ng.3967.","DOI":"10.1038\/ng.3967"},{"issue":"1","key":"2558_CR391","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ol.2018.9583","volume":"17","author":"C Xu","year":"2019","unstructured":"Xu C, Li X, Liu P, Li M, Luo F. Patient-derived xenograft mouse models: A high fidelity tool for individualized medicine. Oncol Lett. 2019;17(1):3\u201310. https:\/\/doi.org\/10.3892\/ol.2018.9583.","journal-title":"Oncol Lett"},{"issue":"1","key":"2558_CR392","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12967-020-02473-y","volume":"18","author":"HY Jung","year":"2020","unstructured":"Jung HY, Kim TH, Lee JE, Kim HK, Cho JH, Choi YS, Shin S, Lee SH, Rhee H, Lee HK, et al. PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applications. J Translational Med. 2020;18(1):307. https:\/\/doi.org\/10.1186\/s12967-020-02473-y.","journal-title":"J Translational Med"},{"key":"2558_CR393","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2021.11.004","volume":"525","author":"M Shi","year":"2022","unstructured":"Shi M, Wang Y, Lin D, Wang Y. Patient-derived xenograft models of neuroendocrine prostate cancer. Cancer Lett. 2022;525:160\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.004.","journal-title":"Cancer Lett"},{"issue":"1","key":"2558_CR394","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12885-023-11434-9","volume":"23","author":"J Gao","year":"2023","unstructured":"Gao J, Lan J, Liao H, Yang F, Qiu P, Jin F, Wang S, Shen L, Chao T, Zhang C, et al. Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper Gastrointestinal cancers: progress and challenges. BMC Cancer. 2023;23(1):1205. https:\/\/doi.org\/10.1186\/s12885-023-11434-9.","journal-title":"BMC Cancer"},{"key":"2558_CR395","doi-asserted-by":"publisher","unstructured":"Huang M, Ramsey S, Xue W, Xie J, Pellissier J, Briggs A. Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models. PharmacoEconomics 2022, 40(3):257\u2013268. https:\/\/doi.org\/10.1007\/s40273-021-01113-7.","DOI":"10.1007\/s40273-021-01113-7"},{"issue":"3","key":"2558_CR396","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/hep.31812","volume":"74","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Wang J, Liu WN, Fong SY, Shuen TWH, Liu M, Harden S, Tan SY, Cheng JY, Tan WWS, et al. Analysis and validation of human targets and treatments using a hepatocellular Carcinoma-Immune humanized mouse model. Hepatology (Baltimore MD). 2021;74(3):1395\u2013410. https:\/\/doi.org\/10.1002\/hep.31812.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"10","key":"2558_CR397","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/annonc\/mdx416","volume":"28","author":"E Izumchenko","year":"2017","unstructured":"Izumchenko E, Paz K, Ciznadija D, Sloma I, Katz A, Vasquez-Dunddel D, Ben-Zvi I, Stebbing J, McGuire W, Harris W, et al. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. Annals Oncology: Official J Eur Soc Med Oncol. 2017;28(10):2595\u2013605. https:\/\/doi.org\/10.1093\/annonc\/mdx416.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"5","key":"2558_CR398","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/path.1936","volume":"208","author":"D Guenot","year":"2006","unstructured":"Guenot D, Gu\u00e9rin E, Aguillon-Romain S, Pencreach E, Schneider A, Neuville A, Chenard MP, Duluc I, Du Manoir S, Brigand C, et al. Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability. J Pathol. 2006;208(5):643\u201352. https:\/\/doi.org\/10.1002\/path.1936.","journal-title":"J Pathol"},{"issue":"12","key":"2558_CR399","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.7150\/thno.32033","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang J, Xing B, Liu W, Li J, Wang X, Li J, Yang J, Ji C, Li Z, Dong B, et al. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis. Theranostics. 2019;9(12):3485\u2013500. https:\/\/doi.org\/10.7150\/thno.32033.","journal-title":"Theranostics"},{"issue":"7","key":"2558_CR400","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12094-010-0540-6","volume":"12","author":"K Jin","year":"2010","unstructured":"Jin K, Teng L, Shen Y, He K, Xu Z, Li G. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2010;12(7):473\u201380. https:\/\/doi.org\/10.1007\/s12094-010-0540-6.","journal-title":"Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"key":"2558_CR401","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","volume":"12","author":"NC Walsh","year":"2017","unstructured":"Walsh NC, Kenney LL, Jangalwe S, Aryee KE, Greiner DL, Brehm MA, Shultz LD. Humanized mouse models of clinical disease. Annu Rev Pathol. 2017;12:187\u2013215. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100332.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2558_CR402","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/14760584.8.1.113","volume":"8","author":"GC Koo","year":"2009","unstructured":"Koo GC, Hasan A, O\u2019Reilly RJ. Use of humanized severe combined immunodeficient mice for human vaccine development. Expert Rev Vaccines. 2009;8(1):113\u201320. https:\/\/doi.org\/10.1586\/14760584.8.1.113.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"2558_CR403","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1096\/fj.201800636R","volume":"33","author":"MA Brehm","year":"2019","unstructured":"Brehm MA, Kenney LL, Wiles MV, Low BE, Tisch RM, Burzenski L, Mueller C, Greiner DL, Shultz LD. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2019;33(3):3137\u201351. https:\/\/doi.org\/10.1096\/fj.201800636R.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"2558_CR404","doi-asserted-by":"publisher","unstructured":"Flerin NC, Bardhi A, Zheng JH, Korom M, Folkvord J, Kovacs C, Benko E, Truong R, Mota T, Connick E, et al. Establishment of a novel humanized mouse model to investigate in vivo activation and depletion of Patient-Derived HIV latent reservoirs. J Virol. 2019;93(6). https:\/\/doi.org\/10.1128\/jvi.02051-18.","DOI":"10.1128\/jvi.02051-18"},{"issue":"8","key":"2558_CR405","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/2326-6066.Cir-18-0874","volume":"7","author":"IM Meraz","year":"2019","unstructured":"Meraz IM, Majidi M, Meng F, Shao R, Ha MJ, Neri S, Fang B, Lin SH, Tinkey PT, Shpall EJ, et al. An improved Patient-Derived xenograft humanized mouse model for evaluation of lung cancer immune responses. Cancer Immunol Res. 2019;7(8):1267\u201379. https:\/\/doi.org\/10.1158\/2326-6066.Cir-18-0874.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2558_CR406","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/bf02825415","volume":"18","author":"C Caldas","year":"1995","unstructured":"Caldas C, Kern SE. K-ras mutation and pancreatic adenocarcinoma. Int J Pancreatology: Official J Int Association Pancreatology. 1995;18(1):1\u20136. https:\/\/doi.org\/10.1007\/bf02825415.","journal-title":"Int J Pancreatology: Official J Int Association Pancreatology"},{"issue":"2","key":"2558_CR407","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bpg.2005.10.002","volume":"20","author":"A Maitra","year":"2006","unstructured":"Maitra A, Kern SE, Hruban RH. Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):211\u201326. https:\/\/doi.org\/10.1016\/j.bpg.2005.10.002.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"19","key":"2558_CR408","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1158\/1078-0432.Ccr-12-0372","volume":"18","author":"S Julien","year":"2012","unstructured":"Julien S, Merino-Trigo A, Lacroix L, Pocard M, Go\u00e9r\u00e9 D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, et al. Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2012;18(19):5314\u201328. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-0372.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"14","key":"2558_CR409","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1128\/jvi.02207-08","volume":"83","author":"DM Brainard","year":"2009","unstructured":"Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin HS, Brooks SF, Knight HL, Eichbaum Q, et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol. 2009;83(14):7305\u201321. https:\/\/doi.org\/10.1128\/jvi.02207-08.","journal-title":"J Virol"},{"issue":"2","key":"2558_CR410","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1182\/blood-2005-11-4388","volume":"108","author":"P Lan","year":"2006","unstructured":"Lan P, Tonomura N, Shimizu A, Wang S, Yang YG. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus\/liver and CD34\u2009+\u2009cell transplantation. Blood. 2006;108(2):487\u201392. https:\/\/doi.org\/10.1182\/blood-2005-11-4388.","journal-title":"Blood"},{"issue":"14","key":"2558_CR411","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1182\/blood-2015-10-676452","volume":"128","author":"Y Saito","year":"2016","unstructured":"Saito Y, Ellegast JM, Rafiei A, Song Y, Kull D, Heikenwalder M, Rongvaux A, Halene S, Flavell RA, Manz MG. Peripheral blood CD34(+) cells efficiently engraft human cytokine knock-in mice. Blood. 2016;128(14):1829\u201333. https:\/\/doi.org\/10.1182\/blood-2015-10-676452.","journal-title":"Blood"},{"key":"2558_CR412","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0065-230x(10)06004-5","volume":"106","author":"JC Walrath","year":"2010","unstructured":"Walrath JC, Hawes JJ, Van Dyke T, Reilly KM. Genetically engineered mouse models in cancer research. Adv Cancer Res. 2010;106:113\u201364. https:\/\/doi.org\/10.1016\/s0065-230x(10)06004-5.","journal-title":"Adv Cancer Res"},{"issue":"7","key":"2558_CR413","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrc2877","volume":"10","author":"J Heyer","year":"2010","unstructured":"Heyer J, Kwong LN, Lowe SW, Chin L. Non-germline genetically engineered mouse models for translational cancer research. Nat Rev Cancer. 2010;10(7):470\u201380. https:\/\/doi.org\/10.1038\/nrc2877.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2558_CR414","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nbt.1595","volume":"28","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Rideout WM 3rd, Zi T, Bressel A, Reddypalli S, Rancourt R, Woo JK, Horner JW, Chin L, Chiu MI, et al. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. Nat Biotechnol. 2010;28(1):71\u20138. https:\/\/doi.org\/10.1038\/nbt.1595.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2558_CR415","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(84)90257-5","volume":"38","author":"TA Stewart","year":"1984","unstructured":"Stewart TA, Pattengale PK, Leder P. Spontaneous mammary adenocarcinomas in Transgenic mice that carry and express MTV\/myc fusion genes. Cell. 1984;38(3):627\u201337. https:\/\/doi.org\/10.1016\/0092-8674(84)90257-5.","journal-title":"Cell"},{"issue":"2","key":"2558_CR416","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0092-8674(84)90367-2","volume":"37","author":"RL Brinster","year":"1984","unstructured":"Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter RD. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell. 1984;37(2):367\u201379. https:\/\/doi.org\/10.1016\/0092-8674(84)90367-2.","journal-title":"Cell"},{"issue":"5556","key":"2558_CR417","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.1067081","volume":"295","author":"C Lois","year":"2002","unstructured":"Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Sci (New York NY). 2002;295(5556):868\u201372. https:\/\/doi.org\/10.1126\/science.1067081.","journal-title":"Sci (New York NY)"},{"key":"2558_CR418","doi-asserted-by":"crossref","unstructured":"Novak A, Guo C, Yang W, Nagy A, Lobe CG. Z\/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis (New York, NY: 2000) 2000, 28(3\u20134):147\u2013155.","DOI":"10.1002\/1526-968X(200011\/12)28:3\/4<147::AID-GENE90>3.0.CO;2-G"},{"issue":"6110","key":"2558_CR419","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/326295a0","volume":"326","author":"MR Kuehn","year":"1987","unstructured":"Kuehn MR, Bradley A, Robertson EJ, Evans MJ. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature. 1987;326(6110):295\u20138. https:\/\/doi.org\/10.1038\/326295a0.","journal-title":"Nature"},{"issue":"6087","key":"2558_CR420","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/323445a0","volume":"323","author":"E Robertson","year":"1986","unstructured":"Robertson E, Bradley A, Kuehn M, Evans M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature. 1986;323(6087):445\u20138. https:\/\/doi.org\/10.1038\/323445a0.","journal-title":"Nature"},{"issue":"1","key":"2558_CR421","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpmo.22","volume":"7","author":"MA McLellan","year":"2017","unstructured":"McLellan MA, Rosenthal NA, Pinto AR. Cre-loxP-Mediated recombination: general principles and experimental considerations. Curr Protocols Mouse Biology. 2017;7(1):1\u201312. https:\/\/doi.org\/10.1002\/cpmo.22.","journal-title":"Curr Protocols Mouse Biology"},{"issue":"5","key":"2558_CR422","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.stemcr.2018.09.014","volume":"11","author":"Z Chen","year":"2018","unstructured":"Chen Z, Ren X, Xu X, Zhang X, Hui Y, Liu Z, Shi L, Fang Y, Ma L, Liu Y, et al. Genetic engineering of human embryonic stem cells for precise cell fate tracing during human lineage development. Stem Cell Rep. 2018;11(5):1257\u201371. https:\/\/doi.org\/10.1016\/j.stemcr.2018.09.014.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"2558_CR423","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/embo-reports\/kve064","volume":"2","author":"M Vooijs","year":"2001","unstructured":"Vooijs M, Jonkers J, Berns A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2001;2(4):292\u20137. https:\/\/doi.org\/10.1093\/embo-reports\/kve064.","journal-title":"EMBO Rep"},{"issue":"19","key":"2558_CR424","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1093\/nar\/24.19.3875","volume":"24","author":"L St-Onge","year":"1996","unstructured":"St-Onge L, Furth PA, Gruss P. Temporal control of the Cre recombinase in Transgenic mice by a Tetracycline responsive promoter. Nucleic Acids Res. 1996;24(19):3875\u20137. https:\/\/doi.org\/10.1093\/nar\/24.19.3875.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2558_CR425","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/35093564","volume":"2","author":"Y Yu","year":"2001","unstructured":"Yu Y, Bradley A. Engineering chromosomal rearrangements in mice. Nat Rev Genet. 2001;2(10):780\u201390. https:\/\/doi.org\/10.1038\/35093564.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"2558_CR426","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ng2045","volume":"39","author":"RA Dickins","year":"2007","unstructured":"Dickins RA, McJunkin K, Hernando E, Premsrirut PK, Krizhanovsky V, Burgess DJ, Kim SY, Cordon-Cardo C, Zender L, Hannon GJ, et al. Tissue-specific and reversible RNA interference in Transgenic mice. Nat Genet. 2007;39(7):914\u201321. https:\/\/doi.org\/10.1038\/ng2045.","journal-title":"Nat Genet"},{"issue":"2","key":"2558_CR427","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1101\/gad1367806","volume":"20","author":"MK Rao","year":"2006","unstructured":"Rao MK, Pham J, Imam JS, MacLean JA, Murali D, Furuta Y, Sinha-Hikim AP, Wilkinson MF. Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis. Genes Dev. 2006;20(2):147\u201352. https:\/\/doi.org\/10.1101\/gad1367806.","journal-title":"Genes Dev"},{"issue":"9","key":"2558_CR428","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1073\/pnas.93.9.3932","volume":"93","author":"Y Wang","year":"1996","unstructured":"Wang Y, Krushel LA, Edelman GM. Targeted DNA recombination in vivo using an adenovirus carrying the Cre recombinase gene. Proc Natl Acad Sci USA. 1996;93(9):3932\u20136. https:\/\/doi.org\/10.1073\/pnas.93.9.3932.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2558_CR429","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s43018-020-0070-2","volume":"1","author":"K Slowicka","year":"2020","unstructured":"Slowicka K, Petta I, Blancke G, Hoste E, Dumas E, Sze M, Vikkula H, Radaelli E, Haigh JJ, Jonckheere S, et al. Zeb2 drives invasive and microbiota-dependent colon carcinoma. Nat Cancer. 2020;1(6):620\u201334. https:\/\/doi.org\/10.1038\/s43018-020-0070-2.","journal-title":"Nat Cancer"},{"issue":"720","key":"2558_CR430","doi-asserted-by":"publisher","first-page":"eadg3049","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, Stockwell B, Kroemer G, Kang R, Tang D. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15(720):eadg3049. https:\/\/doi.org\/10.1126\/scitranslmed.adg3049.","journal-title":"Sci Transl Med"},{"issue":"8","key":"2558_CR431","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1136\/gutjnl-2023-329686","volume":"73","author":"F Zhang","year":"2024","unstructured":"Zhang F, Sahu V, Peng K, Wang Y, Li T, Bala P, Aitymbayev D, Sahgal P, Schaefer A, Der CJ, et al. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut. 2024;73(8):1280\u201391. https:\/\/doi.org\/10.1136\/gutjnl-2023-329686.","journal-title":"Gut"},{"issue":"7165","key":"2558_CR432","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003\u20137. https:\/\/doi.org\/10.1038\/nature06196.","journal-title":"Nature"},{"issue":"7229","key":"2558_CR433","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature07602","volume":"457","author":"N Barker","year":"2009","unstructured":"Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457(7229):608\u201311. https:\/\/doi.org\/10.1038\/nature07602.","journal-title":"Nature"},{"issue":"7368","key":"2558_CR434","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature10408","volume":"478","author":"H Tian","year":"2011","unstructured":"Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, de Sauvage FJ. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 2011;478(7368):255\u20139. https:\/\/doi.org\/10.1038\/nature10408.","journal-title":"Nature"},{"issue":"1","key":"2558_CR435","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2010.09.016","volume":"143","author":"HJ Snippert","year":"2010","unstructured":"Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, Barker N, Klein AM, van Rheenen J, Simons BD, et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell. 2010;143(1):134\u201344. https:\/\/doi.org\/10.1016\/j.cell.2010.09.016.","journal-title":"Cell"},{"issue":"6095","key":"2558_CR436","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","volume":"337","author":"AG Schepers","year":"2012","unstructured":"Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, Clevers H. Lineage tracing reveals Lgr5\u2009+\u2009stem cell activity in mouse intestinal adenomas. Sci (New York NY). 2012;337(6095):730\u20135. https:\/\/doi.org\/10.1126\/science.1224676.","journal-title":"Sci (New York NY)"},{"key":"2558_CR437","doi-asserted-by":"publisher","unstructured":"Gasnier M, Chen TC, Yada S, Sagiraju S, Yoshikawa Y, Perna S, Lim HYG, Lee B, Barker N. NOX1 and NPY1R mark regional colon stem cell populations that serve as cancer origins in vivo. Nat Cell Biol 2025, 27(10):1632\u201346. https:\/\/doi.org\/10.1038\/s41556-025-01763-1.","DOI":"10.1038\/s41556-025-01763-1"},{"key":"2558_CR438","doi-asserted-by":"publisher","unstructured":"Roper J, Martin ES, Hung KE. Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development. Current protocols in pharmacology 2014, 65:14.29.11-10. https:\/\/doi.org\/10.1002\/0471141755.ph1429s65.","DOI":"10.1002\/0471141755.ph1429s65"},{"issue":"1","key":"2558_CR439","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/j.gastro.2020.03.018","volume":"159","author":"Y Ma","year":"2020","unstructured":"Ma Y, Li J, Wang H, Chiu Y, Kingsley CV, Fry D, Delaney SN, Wei SC, Zhang J, Maitra A, et al. Combination of PD-1 inhibitor and OX40 agonist induces tumor rejection and immune memory in mouse models of pancreatic cancer. Gastroenterology. 2020;159(1):306\u2013e319312. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.018.","journal-title":"Gastroenterology"},{"key":"2558_CR440","doi-asserted-by":"publisher","unstructured":"Sharpless NE, Depinho RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nature reviews Drug discovery. 2006;5(9):741-54. https:\/\/doi.org\/10.1038\/nrd2110.","DOI":"10.1038\/nrd2110."},{"issue":"6366","key":"2558_CR441","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr., Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992;356(6366):215\u201321. https:\/\/doi.org\/10.1038\/356215a0.","journal-title":"Nature"},{"issue":"9","key":"2558_CR442","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"J Seok","year":"2013","unstructured":"Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 2013;110(9):3507\u201312. https:\/\/doi.org\/10.1073\/pnas.1222878110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2558_CR443","doi-asserted-by":"publisher","unstructured":"Li E, Lin L, Chen CW, Ou DL. Mouse models for immunotherapy in hepatocellular carcinoma. Cancers. 2019;11(11). https:\/\/doi.org\/10.3390\/cancers11111800.","DOI":"10.3390\/cancers11111800"},{"issue":"2","key":"2558_CR444","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2967\/jnumed.110.081943","volume":"52","author":"C Xiong","year":"2011","unstructured":"Xiong C, Huang M, Zhang R, Song S, Lu W, Flores L 2nd, Gelovani J, Li C. In vivo small-animal PET\/CT of EphB4 receptors using 64Cu-labeled peptide. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2011;52(2):241\u20138. https:\/\/doi.org\/10.2967\/jnumed.110.081943.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"issue":"3","key":"2558_CR445","doi-asserted-by":"publisher","first-page":"e17384","DOI":"10.1371\/journal.pone.0017384","volume":"6","author":"SJ Miller","year":"2011","unstructured":"Miller SJ, Joshi BP, Feng Y, Gaustad A, Fearon ER, Wang TD. In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe. PLoS ONE. 2011;6(3):e17384. https:\/\/doi.org\/10.1371\/journal.pone.0017384.","journal-title":"PLoS ONE"},{"issue":"1","key":"2558_CR446","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1349-7006.2006.00348.x","volume":"98","author":"Y Yamada","year":"2007","unstructured":"Yamada Y, Mori H. Multistep carcinogenesis of the colon in Apc(Min\/+) mouse. Cancer Sci. 2007;98(1):6\u201310. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00348.x.","journal-title":"Cancer Sci"},{"issue":"42","key":"2558_CR447","doi-asserted-by":"publisher","first-page":"E6409","DOI":"10.1073\/pnas.1613601113","volume":"113","author":"DG McFadden","year":"2016","unstructured":"McFadden DG, Politi K, Bhutkar A, Chen FK, Song X, Pirun M, Santiago PM, Kim-Kiselak C, Platt JT, Lee E, et al. Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma. Proc Natl Acad Sci USA. 2016;113(42):E6409\u201317. https:\/\/doi.org\/10.1073\/pnas.1613601113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2558_CR448","doi-asserted-by":"publisher","unstructured":"Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther 2017, 16(11):2598\u2013608. https:\/\/doi.org\/10.1158\/1535-7163.Mct-17-0386.","DOI":"10.1158\/1535-7163.Mct-17-0386"},{"issue":"4","key":"2558_CR449","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nbt.3155","volume":"33","author":"LE Dow","year":"2015","unstructured":"Dow LE, Fisher J, O\u2019Rourke KP, Muley A, Kastenhuber ER, Livshits G, Tschaharganeh DF, Socci ND, Lowe SW. Inducible in vivo genome editing with CRISPR-Cas9. Nat Biotechnol. 2015;33(4):390\u20134. https:\/\/doi.org\/10.1038\/nbt.3155.","journal-title":"Nat Biotechnol"},{"key":"2558_CR450","doi-asserted-by":"publisher","unstructured":"Till JE, Yoon C, Kim BJ, Roby K, Addai P, Jonokuchi E, Tang LH, Yoon SS, Ryeom S. Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-Cadherin expression. Cancer Res 2017, 77(19):5349\u201359. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-0061.","DOI":"10.1158\/0008-5472.Can-17-0061"},{"issue":"12","key":"2558_CR451","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41556-021-00793-9","volume":"23","author":"A Fatehullah","year":"2021","unstructured":"Fatehullah A, Terakado Y, Sagiraju S, Tan TL, Sheng T, Tan SH, Murakami K, Swathi Y, Ang N, Rajarethinam R, et al. A tumour-resident Lgr5(+) stem-cell-like pool drives the establishment and progression of advanced gastric cancers. Nat Cell Biol. 2021;23(12):1299\u2013313. https:\/\/doi.org\/10.1038\/s41556-021-00793-9.","journal-title":"Nat Cell Biol"},{"key":"2558_CR452","doi-asserted-by":"publisher","unstructured":"Pearce SC, Coia HG, Karl JP, Pantoja-Feliciano IG, Zachos NC, Racicot K. Intestinal in vitro and ex vivo models to study Host-Microbiome interactions and acute stressors. Front Physiol 2018, 9:1584. https:\/\/doi.org\/10.3389\/fphys.2018.01584.","DOI":"10.3389\/fphys.2018.01584"},{"key":"2558_CR453","doi-asserted-by":"publisher","unstructured":"Rahman S, Ghiboub M, Donkers JM, van de Steeg E, van Tol EAF, Hakvoort TBM, de Jonge WJ. The progress of intestinal epithelial models from cell lines to Gut-On-Chip. Int J Mol Sci. 2021;22(24). https:\/\/doi.org\/10.3390\/ijms222413472.","DOI":"10.3390\/ijms222413472"},{"key":"2558_CR454","doi-asserted-by":"publisher","first-page":"204173142098520","DOI":"10.1177\/2041731420985202","volume":"12","author":"J Creff","year":"2021","unstructured":"Creff J, Malaquin L, Besson A. In vitro models of intestinal epithelium: toward bioengineered systems. J Tissue Eng. 2021;12:2041731420985202. https:\/\/doi.org\/10.1177\/2041731420985202.","journal-title":"J Tissue Eng"},{"issue":"9","key":"2558_CR455","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.drudis.2016.06.024","volume":"21","author":"M Chatzinikolaidou","year":"2016","unstructured":"Chatzinikolaidou M. Cell spheroids: the new frontiers in in vitro models for cancer drug validation. Drug Discovery Today. 2016;21(9):1553\u201360. https:\/\/doi.org\/10.1016\/j.drudis.2016.06.024.","journal-title":"Drug Discovery Today"},{"issue":"4849","key":"2558_CR456","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.2451290","volume":"240","author":"RM Sutherland","year":"1988","unstructured":"Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Sci (New York NY). 1988;240(4849):177\u201384. https:\/\/doi.org\/10.1126\/science.2451290.","journal-title":"Sci (New York NY)"},{"issue":"1","key":"2558_CR457","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-020-00931-0","volume":"13","author":"M Zanoni","year":"2020","unstructured":"Zanoni M, Cortesi M, Zamagni A, Arienti C, Pignatta S, Tesei A. Modeling neoplastic disease with spheroids and organoids. J Hematol Oncol. 2020;13(1):97. https:\/\/doi.org\/10.1186\/s13045-020-00931-0.","journal-title":"J Hematol Oncol"},{"issue":"18","key":"2558_CR458","doi-asserted-by":"publisher","first-page":"e2202609","DOI":"10.1002\/adhm.202202609","volume":"12","author":"W Li","year":"2023","unstructured":"Li W, Zhou Z, Zhou X, Khoo BL, Gunawan R, Chin YR, Zhang L, Yi C, Guan X, Yang M. 3D biomimetic models to reconstitute tumor microenvironment in vitro: Spheroids, Organoids, and tumor-on-a-Chip. Adv Healthc Mater. 2023;12(18):e2202609. https:\/\/doi.org\/10.1002\/adhm.202202609.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"2558_CR459","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1039\/c7lc00815e","volume":"18","author":"M Rothbauer","year":"2018","unstructured":"Rothbauer M, Zirath H, Ertl P. Recent advances in microfluidic technologies for cell-to-cell interaction studies. Lab Chip. 2018;18(2):249\u201370. https:\/\/doi.org\/10.1039\/c7lc00815e.","journal-title":"Lab Chip"},{"issue":"1","key":"2558_CR460","doi-asserted-by":"publisher","first-page":"101710","DOI":"10.1016\/j.jksus.2021.101710","volume":"34","author":"S Seidi","year":"2022","unstructured":"Seidi S, Eftekhari A, Khusro A, Heris RS, Sahibzada MUK, Gajdacs M. Simulation and modeling of physiological processes of vital organs in organ-on-a-chip biosystem. J King Saud University-Science. 2022;34(1):101710.","journal-title":"J King Saud University-Science"},{"key":"2558_CR461","doi-asserted-by":"publisher","unstructured":"Liu Y, Yin T, Feng Y, Cona MM, Huang G, Liu J, Song S, Jiang Y, Xia Q, Swinnen JV et al. Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research. Quant Imaging Med Surg 2015, 5(5):708\u201329. https:\/\/doi.org\/10.3978\/j.issn.2223-4292.2015.06.01.","DOI":"10.3978\/j.issn.2223-4292.2015.06.01"},{"issue":"1","key":"2558_CR462","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","volume":"163","author":"CP Day","year":"2015","unstructured":"Day CP, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell. 2015;163(1):39\u201353. https:\/\/doi.org\/10.1016\/j.cell.2015.08.068.","journal-title":"Cell"},{"issue":"1","key":"2558_CR463","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","volume":"50","author":"J Jung","year":"2018","unstructured":"Jung J, Seol HS, Chang S. The generation and application of Patient-Derived xenograft model for cancer research. Cancer Res Treat. 2018;50(1):1\u201310. https:\/\/doi.org\/10.4143\/crt.2017.307.","journal-title":"Cancer Res Treat"},{"issue":"7","key":"2558_CR464","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.18632\/oncotarget.6919","volume":"7","author":"AT Pearson","year":"2016","unstructured":"Pearson AT, Finkel KA, Warner KA, N\u00f6r F, Tice D, Martins MD, Jackson TL, N\u00f6r JE. Patient-derived xenograft (PDX) tumors increase growth rate with time. Oncotarget. 2016;7(7):7993\u20138005. https:\/\/doi.org\/10.18632\/oncotarget.6919.","journal-title":"Oncotarget"},{"key":"2558_CR465","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1158\/2159-8290.Cd-18-0044","volume":"8","author":"B Olson","year":"2018","unstructured":"Olson B, Li Y, Lin Y, Liu ET, Patnaik A. Mouse models for cancer immunotherapy research. Cancer Discov. 2018;8(11):1358\u201365. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-0044.","journal-title":"Cancer Discov"},{"key":"2558_CR466","doi-asserted-by":"publisher","unstructured":"Liu WN, Fong SY, Tan WWS, Tan SY, Liu M, Cheng JY, Lim S, Suteja L, Huang EK, Chan JKY, et al. Establishment and characterization of humanized mouse NPC-PDX model for testing immunotherapy. Cancers. 2020;12(4). https:\/\/doi.org\/10.3390\/cancers12041025.","DOI":"10.3390\/cancers12041025"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02558-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:22:29Z","timestamp":1774524149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02558-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":466,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2558"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02558-6","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is not applicable for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}